≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Combined immunodeficiencies

DOID EFO Endpoint Browser PheWeb

D3_COMBIMMUDEF

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D81
  • Cause of death: ICD-10 — D81

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

401

6. Filter based on genotype QC (FinnGen only)

383

Control definitions (FinnGen only)

Control exclude
D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D80-D89
Name in latin
Deficientiae immunales mixtae

Similar endpoints

↥

List of similar endpoints to Combined immunodeficiencies based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3113 1722 1368
Only index persons 2640 1511 1129
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.04
Only index persons 0.05 0.06 0.04
Median age at first event (years)
Whole population 56.62 54.81 58.78
Only index persons 54.63 53.01 56.80

-FinnGen-

Key figures

All Female Male
Number of individuals 383 233 150
Unadjusted period prevalence (%) 0.08 0.08 0.07
Median age at first event (years) 53.87 49.26 61.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
401
Matched controls
4010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D81.4
ICD-10 Finland
Nezelof syndrome
+∞
171.5
152
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
120.0
109
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
9.6
101.9
155
246
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.3
89.1
118
156
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
53.3
50
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
6.5
40.7
74
134
ZXD05
NOMESCO Finland
Urgent procedure
3.8
38.5
198
816
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
38.1
36
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
31.6
59
109
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
23.6
110
407
D81.2
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
+∞
23.1
22
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
23.1
96
330
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
22.1
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
21.8
199
1058
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
21.6
88
298
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
21.6
151
700
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
21.0
20
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.2
20.6
37
65
J01MA12
ATC
levofloxacin; systemic
3.1
20.5
110
439
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
19.2
161
809
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
8.1
18.9
26
34
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
18.9
18
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.8
18.8
45
103
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
7.9
18.4
26
35
Z3226
NOMESCO Finland
Physiotherapist
2.9
18.1
112
480
L04AX01
ATC
azathioprine; systemic
6.1
17.9
32
56
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
17.9
97
387
J01FF01
ATC
clindamycin; systemic
2.6
17.4
142
698
N02AX02
ATC
tramadol; systemic, rectal
2.4
17.2
214
1277
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
16.9
65
210
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
16.8
228
1411
C03CA01
ATC
furosemide; systemic
2.4
16.2
163
879
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
15.8
116
539
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
15.7
15
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.6
15.7
26
42
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
15.2
70
253
UJF32
NOMESCO Finland
Coloscopy
2.5
15.0
130
651
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
14.4
117
567
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.8
14.4
47
136
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.0
14.3
26
46
P01AB01
ATC
metronidazole; oral, rectal
2.3
14.2
196
1193
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
14.2
184
1092
J01MA02
ATC
ciprofloxacin; systemic
2.2
13.9
186
1115
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
13.4
63
229
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.3
13.4
36
90
R50.9
ICD-10 Finland
Fever, unspecified
2.7
13.3
85
365
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
13.3
98
452
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
13.0
100
470
Z3231
NOMESCO Finland
Registered nurse
2.3
12.6
139
764
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
12.6
12
*
D81.3
ICD-10 Finland
Adenosine deaminase [ADA] deficiency
+∞
12.6
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
12.4
112
566
WZC00
NOMESCO Finland
Treatment plan or consultation
2.2
12.3
166
988
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
12.1
55
196
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
12.1
201
1293
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
12.1
67
267
J01DA01
ATC
[U] cefalexin
2.2
11.7
273
1986
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
11.6
25
52
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
11.5
11
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.0
11.5
55
202
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
11.4
45
147
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.4
11.4
23
45
R4110
NOMESCO Finland
Physiotherapy
2.2
11.3
139
793
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
11.2
44
143
WX002
NOMESCO Finland
Sedation and analgesia
2.4
11.2
96
472
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.1
10.9
31
81
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
10.8
62
251
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
10.7
165
1020
ZXA00
NOMESCO Finland
Right side
2.1
10.7
133
759
WX882
NOMESCO Finland
High dependency care
5.2
10.6
22
44
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.2
10.6
22
44
N03AX16
ATC
[U] pregabalin
2.2
10.6
113
607
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
10.4
33
93
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
10.3
66
282
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
10.2
173
1101
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.0
10.1
48
175
WX892
NOMESCO Finland
Monitored bed care
3.1
10.1
44
153
H02AB09
ATC
hydrocortisone; systemic
5.1
9.9
21
43
SPAT1255
SPAT
Intravenous administration of medicine
3.5
9.8
35
107
Z2221
NOMESCO Finland
Medical doctor
2.1
9.6
129
753
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
9.5
91
466
LWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gynaecological surgery
18.1
9.5
14
8
ZZA00
NOMESCO Finland
Split skin graft
4.7
9.4
22
49
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.2
9.2
25
63
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.4
9.1
18
20
JAH00
NOMESCO Finland
Laparotomy
4.3
9.1
24
59
L04AA01
ATC
[U] ciclosporin
12.9
8.9
15
12
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
8.8
157
1006
A46
ICD-10 Finland
Erysipelas
2.3
8.8
73
351
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
8.7
35
116
J01DB01
ATC
cefalexin; oral
2.3
8.6
335
2774
R60.9
ICD-10 Finland
Oedema, unspecified
3.4
8.6
32
101
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
8.4
122
726
ZXE00
NOMESCO Finland
One hour or less
1.9
8.4
167
1106
X58
ICD-10 Finland
Exposure to other specified factors
2.3
8.3
69
332
Z2446
NOMESCO Finland
Social worker
2.9
8.2
39
142
C03DA01
ATC
spironolactone; oral
2.4
8.2
62
286
JN4BD
NOMESCO Finland
Extensive body CT
2.5
8.1
53
228
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
8.1
53
228
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.5
8.1
20
32
B01AA03
ATC
warfarin; systemic
2.1
8.1
92
501
WX872
NOMESCO Finland
Intensive care
3.5
8.1
28
84
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
7.9
49
206
B01AB05
ATC
enoxaparin; parenteral
1.9
7.8
138
874
XLA10, ,
NOMESCO Finland
3.6
7.8
26
76
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
7.8
76
390
JAH01
NOMESCO Finland
Laparoscopy
3.3
7.7
29
92
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.3
7.6
14
14
H02AB06
ATC
prednisolone; systemic
1.8
7.6
198
1413
ZX120
NOMESCO Finland
Intravenous
2.5
7.4
50
219
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.0
7.4
34
122
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
7.3
46
194
A06AD11
ATC
lactulose; oral
2.1
7.3
73
377
ZXA05
NOMESCO Finland
Left side
1.9
7.3
113
683
D81.6
ICD-10 Finland
Major histocompatibility complex class I deficiency
+∞
7.3
7
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
7.3
7
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
7.3
7
*
K92.1
ICD-10 Finland
Melaena
3.1
7.2
30
101
6BA02, ,
NOMESCO Finland
30.6
7.2
9
*
A01AB10
ATC
natamycin; local oral
4.2
7.2
19
47
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
7.1
36
136
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
7.1
282
2258
M05BA07
ATC
risedronic acid; oral
4.0
7.1
20
52
A02BA02
ATC
ranitidine; systemic
2.0
7.0
93
533
J01CF02
ATC
cloxacillin; systemic
5.6
7.0
19
35
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.9
7.0
33
120
ZXD35
NOMESCO Finland
Usual procedure
3.7
7.0
22
62
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
6.9
41
168
A07AA02
ATC
nystatin; oral
2.9
6.9
32
115
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
6.8
26
83
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.8
6.8
21
58
SPAT1262
SPAT
Handing over of treatment supplies
2.1
6.8
73
387
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.6
6.8
13
14
X57
ICD-10 Finland
Unspecified privation
4.4
6.8
17
40
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
6.8
19
49
N05CF01
ATC
zopiclone; oral
1.8
6.8
142
942
TGC00
NOMESCO Finland
Bronchial lavation
4.1
6.7
18
45
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
6.7
60
297
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
6.7
50
229
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
6.7
21
59
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.1
6.7
17
29
J02AC01
ATC
fluconazole; systemic
1.7
6.6
166
1157
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
12.5
6.6
11
9
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.9
6.6
19
50
M05BA04
ATC
alendronic acid; oral
2.5
6.6
43
185
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.6
6.6
38
154
T81.9
ICD-10 Finland
Unspecified complication of procedure
6.4
6.5
16
26
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.5
6.5
22
65
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
6.5
44
193
A10AE04
ATC
insulin glargine; parenteral
2.4
6.5
46
206
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
6.4
19
51
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.2
6.4
25
81
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
14.6
6.4
10
7
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.5
6.4
22
66
J01MA14
ATC
moxifloxacin; systemic
2.4
6.4
43
188
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
6.3
25
82
EBA10
NOMESCO Finland
Operative extraction of tooth
2.3
6.3
48
222
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.3
6.3
24
77
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
6.3
42
183
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
6.3
6
*
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
+∞
6.3
6
*
NHW10
NOMESCO Finland
Reoperation for deep infection in in surgery of ankle or foot
+∞
6.3
6
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.4
6.2
22
67
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
6.2
71
386
127
Kela drug reimbursment
Transplant complication
7.9
6.2
13
17
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
6.1
31
117
L03AA02
ATC
filgrastim; parenteral
3.7
6.1
19
53
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.9
6.1
14
21
WW200
NOMESCO Finland
Immunization
5.3
6.1
17
33
J04AB02
ATC
rifampicin; systemic
10.2
6.1
11
11
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.1
95
574
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.1
66
352
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.7
6.1
16
29
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.2
6.1
15
25
L28
ICPC
Limited function/disability (L)
1.9
6.0
84
488

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Outpatient Visit
OP [9202]
8.7e-01
1.8e+00
2.5e+00
5.0e+00
2.2e+00
1.7e+00
1.2e+00
cases:75.00%
controls:55.68%
cases:76.57%
controls:35.76%
cases:50.63%
controls:7.85%
cases:29.47%
controls:0.28%
cases:43.91%
controls:8.23%
cases:76.64%
controls:37.16%
cases:88.09%
controls:69.66%
297
2209
99
1758
304
1421
93
2553
201
312
196
3662
117
11
280
3963
173
327
221
3644
292
1463
89
2474
318
2615
43
1139
Outpatient Hospital
22 [8756]
9.2e-01
2.0e+00
4.3e+00
—
2.5e+00
1.8e+00
1.2e+00
cases:44.95%
controls:24.50%
cases:37.53%
controls:7.75%
cases:38.54%
controls:0.88%
—
—
cases:11.42%
controls:1.06%
cases:32.55%
controls:7.32%
cases:53.19%
controls:25.36%
178
972
218
2995
149
308
248
3666
153
35
244
3939
—
45
42
349
3929
124
288
257
3649
192
952
169
2802
Medical doctor
Z2221 [2001311556]
8.6e-01
1.8e+00
3.3e+00
—
2.9e+00
1.9e+00
1.5e+00
cases:8.59%
controls:3.83%
cases:9.82%
controls:1.81%
cases:6.30%
controls:0.25%
—
—
cases:5.84%
controls:0.35%
cases:9.45%
controls:1.52%
cases:15.24%
controls:3.73%
34
152
362
3815
39
72
358
3902
25
10
372
3964
—
23
14
371
3957
36
60
345
3877
55
140
306
3614
Upper gastrointestinal surgery
106 [44777669]
1.1e+00
1.8e+00
3.9e+00
1.0e+50
2.4e+00
1.7e+00
1.1e+00
cases:12.12%
controls:4.21%
cases:10.33%
controls:1.86%
cases:9.32%
controls:0.20%
cases:7.05%
controls:0.00%
cases:3.55%
controls:0.33%
cases:9.45%
controls:1.83%
cases:19.67%
controls:7.41%
48
167
348
3800
41
74
356
3900
37
8
360
3966
28
0
369
3974
14
13
380
3958
36
72
345
3865
71
278
290
3476
Inpatient Hospital
21 [8717]
7.6e-01
1.8e+00
3.8e+00
—
2.7e+00
1.6e+00
1.1e+00
cases:53.28%
controls:34.81%
cases:47.10%
controls:12.36%
cases:43.83%
controls:1.71%
—
—
cases:20.81%
controls:1.74%
cases:37.80%
controls:11.33%
cases:60.11%
controls:32.39%
211
1381
185
2586
187
491
210
3483
174
68
223
3906
—
82
69
312
3902
144
446
237
3491
217
1216
144
2538
Infectious Disease
44 [38004484]
2.1e+00
3.3e+00
—
1.0e+50
—
3.5e+00
2.5e+00
cases:4.80%
controls:0.63%
cases:7.05%
controls:0.28%
—
—
cases:5.29%
controls:0.00%
—
—
cases:8.14%
controls:0.28%
cases:10.53%
controls:0.96%
19
25
377
3942
28
11
369
3963
—
21
0
376
3974
—
31
11
350
3926
38
36
323
3718
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.7e+00
2.8e+00
1.0e+50
1.0e+50
1.0e+50
4.5e+00
2.3e+00
cases:4.55%
controls:0.83%
cases:7.30%
controls:0.48%
cases:10.33%
controls:0.00%
cases:6.30%
controls:0.00%
cases:12.44%
controls:0.00%
cases:12.07%
controls:0.15%
cases:6.65%
controls:0.72%
18
33
378
3934
29
19
368
3955
41
0
356
3974
25
0
372
3974
49
0
345
3971
46
6
335
3931
24
27
337
3727
One hour or less
ZXE00 [2001311394]
9.7e-01
1.9e+00
3.3e+00
1.0e+50
2.6e+00
1.6e+00
9.2e-01
cases:11.62%
controls:4.74%
cases:10.33%
controls:1.71%
cases:5.54%
controls:0.23%
cases:4.79%
controls:0.00%
cases:2.54%
controls:0.20%
cases:6.56%
controls:1.40%
cases:13.85%
controls:6.05%
46
188
350
3779
41
68
356
3906
22
9
375
3965
19
0
378
3974
10
8
384
3963
25
55
356
3882
50
227
311
3527
metronidazole; oral, rectal
P01AB01 [21604857]
9.9e-01
1.4e+00
2.6e+00
1.0e+50
3.8e+00
1.4e+00
7.0e-01
cases:13.89%
controls:5.67%
cases:6.05%
controls:1.51%
cases:2.27%
controls:0.18%
cases:2.02%
controls:0.00%
cases:5.33%
controls:0.13%
cases:4.46%
controls:1.17%
cases:10.80%
controls:5.65%
55
225
341
3742
24
60
373
3914
9
7
388
3967
8
0
389
3974
21
5
373
3966
17
46
364
3891
39
212
322
3542
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2.5e+00
2.3e+00
—
—
—
2.8e+00
3.0e+00
cases:1.77%
controls:0.15%
cases:1.51%
controls:0.15%
—
—
—
—
—
—
cases:2.10%
controls:0.13%
cases:5.26%
controls:0.27%
7
6
389
3961
6
6
391
3968
—
—
—
8
5
373
3932
19
10
342
3744
General Surgery
2 [38004447]
7.6e-01
1.5e+00
3.2e+00
—
2.7e+00
1.5e+00
8.0e-01
cases:37.37%
controls:21.86%
cases:25.94%
controls:7.32%
cases:18.39%
controls:0.91%
—
—
cases:13.20%
controls:0.98%
cases:25.46%
controls:7.39%
cases:34.63%
controls:19.26%
148
867
248
3100
103
291
294
3683
73
36
324
3938
—
52
39
342
3932
97
291
284
3646
125
723
236
3031
Office Visit
OMOP4822458 [581477]
8.5e-01
2.0e+00
2.3e+00
1.0e+50
2.8e+00
1.4e+00
1.0e+00
cases:15.15%
controls:7.08%
cases:14.86%
controls:2.29%
cases:3.78%
controls:0.40%
cases:4.03%
controls:0.00%
cases:6.09%
controls:0.38%
cases:10.76%
controls:2.95%
cases:21.33%
controls:8.68%
60
281
336
3686
59
91
338
3883
15
16
382
3958
16
0
381
3974
24
15
370
3956
41
116
340
3821
77
326
284
3428
Urgent procedure
ZXD05 [2001311386]
9.3e-01
2.2e+00
4.1e+00
1.0e+50
—
2.0e+00
1.1e+00
cases:8.59%
controls:3.58%
cases:7.30%
controls:0.91%
cases:7.05%
controls:0.13%
cases:8.56%
controls:0.00%
—
—
cases:5.25%
controls:0.71%
cases:11.91%
controls:4.26%
34
142
362
3825
29
36
368
3938
28
5
369
3969
34
0
363
3974
—
20
28
361
3909
43
160
318
3594
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.4e+00
2.6e+00
—
—
—
2.8e+00
2.4e+00
cases:2.27%
controls:0.20%
cases:2.27%
controls:0.18%
—
—
—
—
—
—
cases:2.36%
controls:0.15%
cases:6.09%
controls:0.56%
9
8
387
3959
9
7
388
3967
—
—
—
9
6
372
3931
22
21
339
3733
Emergency Room Visit
ER [9203]
8.1e-01
1.4e+00
3.3e+00
—
2.3e+00
1.4e+00
8.9e-01
cases:45.71%
controls:27.25%
cases:32.75%
controls:10.77%
cases:24.43%
controls:1.23%
—
—
cases:13.96%
controls:1.59%
cases:32.02%
controls:10.39%
cases:55.40%
controls:33.75%
181
1081
215
2886
130
428
267
3546
97
49
300
3925
—
55
63
339
3908
122
409
259
3528
200
1267
161
2487
Scheduled procedure
ZXD10 [2001311387]
9.8e-01
1.8e+00
4.3e+00
1.0e+50
1.9e+00
1.8e+00
1.1e+00
cases:13.64%
controls:5.60%
cases:11.84%
controls:2.11%
cases:10.08%
controls:0.15%
cases:2.77%
controls:0.00%
cases:1.52%
controls:0.23%
cases:9.71%
controls:1.78%
cases:17.17%
controls:6.37%
54
222
342
3745
47
84
350
3890
40
6
357
3968
11
0
386
3974
6
9
388
3962
37
70
344
3867
62
239
299
3515
Medical Oncology
90 [38004507]
1.1e+00
1.7e+00
2.1e+00
—
2.1e+00
1.9e+00
1.1e+00
cases:5.30%
controls:1.92%
cases:6.30%
controls:1.21%
cases:2.52%
controls:0.33%
—
—
cases:2.28%
controls:0.28%
cases:8.40%
controls:1.32%
cases:9.42%
controls:3.28%
21
76
375
3891
25
48
372
3926
10
13
387
3961
—
9
11
385
3960
32
52
349
3885
34
123
327
3631
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
1.8e+00
2.7e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
2.0e+00
cases:4.29%
controls:0.76%
cases:5.04%
controls:0.35%
cases:8.06%
controls:0.00%
cases:5.79%
controls:0.00%
cases:8.88%
controls:0.00%
cases:7.09%
controls:0.25%
cases:5.82%
controls:0.83%
17
30
379
3937
20
14
377
3960
32
0
365
3974
23
0
374
3974
35
0
359
3971
27
10
354
3927
21
31
340
3723
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.2e+00
2.2e+00
—
—
—
2.2e+00
3.1e+00
cases:2.02%
controls:0.23%
cases:1.76%
controls:0.20%
—
—
—
—
—
—
cases:1.84%
controls:0.20%
cases:3.60%
controls:0.16%
8
9
388
3958
7
8
390
3966
—
—
—
7
8
374
3929
13
6
348
3748
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
5.4e-01
1.2e+00
3.4e+00
—
2.6e+00
1.3e+00
8.3e-01
cases:8.59%
controls:5.19%
cases:5.04%
controls:1.56%
cases:4.53%
controls:0.15%
—
—
cases:2.03%
controls:0.15%
cases:6.82%
controls:2.01%
cases:12.74%
controls:5.99%
34
206
362
3761
20
62
377
3912
18
6
379
3968
—
8
6
386
3965
26
79
355
3858
46
225
315
3529
Thorax X-ray examination
GD1AA [2001303617]
1.1e+00
2.1e+00
2.5e+00
—
1.6e+00
2.1e+00
1.6e+00
cases:9.60%
controls:3.33%
cases:10.33%
controls:1.36%
cases:2.02%
controls:0.18%
—
—
cases:1.27%
controls:0.25%
cases:9.45%
controls:1.30%
cases:20.78%
controls:5.09%
38
132
358
3835
41
54
356
3920
8
7
389
3967
—
5
10
389
3961
36
51
345
3886
75
191
286
3563
cefalexin; oral
J01DB01 [21602870]
8.6e-01
1.2e+00
2.7e+00
—
2.9e+00
1.0e+00
6.5e-01
cases:46.21%
controls:26.62%
cases:24.69%
controls:8.78%
cases:12.85%
controls:1.01%
—
—
cases:18.78%
controls:1.26%
cases:22.31%
controls:9.19%
cases:43.77%
controls:28.90%
183
1056
213
2911
98
349
299
3625
51
40
346
3934
—
74
50
320
3921
85
362
296
3575
158
1085
203
2669
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.0e+00
1.3e+00
1.9e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:13.38%
controls:5.34%
cases:8.56%
controls:2.44%
cases:2.52%
controls:0.40%
—
—
cases:2.28%
controls:0.25%
cases:9.19%
controls:1.83%
cases:18.56%
controls:6.74%
53
212
343
3755
34
97
363
3877
10
16
387
3958
—
9
10
385
3961
35
72
346
3865
67
253
294
3501
Gastroenterology
10 [38004455]
1.2e+00
2.2e+00
2.5e+00
1.0e+50
—
1.9e+00
1.4e+00
cases:6.31%
controls:1.94%
cases:7.30%
controls:0.86%
cases:1.76%
controls:0.15%
cases:1.51%
controls:0.00%
—
—
cases:7.35%
controls:1.17%
cases:13.02%
controls:3.57%
25
77
371
3890
29
34
368
3940
7
6
390
3968
6
0
391
3974
—
28
46
353
3891
47
134
314
3620
FEV1
20150-9 [3024653]
1.5e+00
2.8e+00
—
—
—
2.1e+00
2.6e+00
cases:2.53%
controls:0.55%
cases:2.02%
controls:0.13%
—
—
—
—
—
—
cases:2.10%
controls:0.25%
cases:6.09%
controls:0.48%
10
22
386
3945
8
5
389
3969
—
—
—
8
10
373
3927
22
18
339
3736
FEV1/FVC
19926-5 [3011505]
1.5e+00
2.8e+00
—
—
—
2.1e+00
2.6e+00
cases:2.53%
controls:0.55%
cases:2.02%
controls:0.13%
—
—
—
—
—
—
cases:2.10%
controls:0.25%
cases:6.09%
controls:0.48%
10
22
386
3945
8
5
389
3969
—
—
—
8
10
373
3927
22
18
339
3736
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.5e+00
2.8e+00
—
—
—
2.1e+00
2.6e+00
cases:2.53%
controls:0.55%
cases:2.02%
controls:0.13%
—
—
—
—
—
—
cases:2.10%
controls:0.25%
cases:6.09%
controls:0.48%
10
22
386
3945
8
5
389
3969
—
—
—
8
10
373
3927
22
18
339
3736
Pulmonary Disease
29 [38004472]
7.3e-01
1.4e+00
2.3e+00
—
1.8e+00
1.4e+00
1.3e+00
cases:11.62%
controls:5.95%
cases:10.58%
controls:2.82%
cases:4.28%
controls:0.45%
—
—
cases:2.54%
controls:0.43%
cases:11.02%
controls:2.84%
cases:21.61%
controls:7.09%
46
236
350
3731
42
112
355
3862
17
18
380
3956
—
10
17
384
3954
42
112
339
3825
78
266
283
3488
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
8.3e-01
1.4e+00
2.4e+00
—
2.3e+00
1.8e+00
9.7e-01
cases:5.05%
controls:2.27%
cases:5.54%
controls:1.43%
cases:2.52%
controls:0.23%
—
—
cases:2.54%
controls:0.25%
cases:7.09%
controls:1.27%
cases:13.85%
controls:5.73%
20
90
376
3877
22
57
375
3917
10
9
387
3965
—
10
10
384
3961
27
50
354
3887
50
215
311
3539
Differential panel, method unspecified - Blood
69738-3 [42870588]
9.6e-01
1.7e+00
2.3e+00
—
2.0e+00
1.7e+00
1.2e+00
cases:3.79%
controls:1.49%
cases:5.04%
controls:0.96%
cases:2.27%
controls:0.23%
—
—
cases:1.78%
controls:0.25%
cases:3.67%
controls:0.71%
cases:9.42%
controls:3.01%
15
59
381
3908
20
38
377
3936
9
9
388
3965
—
7
10
387
3961
14
28
367
3909
34
113
327
3641
Intravenous
ZX120 [2001311495]
1.6e+00
2.3e+00
—
—
—
2.7e+00
2.2e+00
cases:2.78%
controls:0.58%
cases:1.76%
controls:0.18%
—
—
—
—
—
—
cases:1.84%
controls:0.13%
cases:4.43%
controls:0.51%
11
23
385
3944
7
7
390
3967
—
—
—
7
5
374
3932
16
19
345
3735
Orthopedic Surgery
20 [38004465]
8.1e-01
1.4e+00
2.5e+00
1.0e+50
2.0e+00
1.2e+00
9.3e-01
cases:19.19%
controls:9.58%
cases:12.34%
controls:3.47%
cases:6.05%
controls:0.53%
cases:4.28%
controls:0.00%
cases:4.06%
controls:0.58%
cases:11.81%
controls:3.78%
cases:25.48%
controls:11.88%
76
380
320
3587
49
138
348
3836
24
21
373
3953
17
0
380
3974
16
23
378
3948
45
149
336
3788
92
446
269
3308
Physiotherapist
Z3226 [2001311560]
1.2e+00
2.1e+00
2.3e+00
—
—
1.8e+00
1.3e+00
cases:6.57%
controls:2.14%
cases:6.80%
controls:0.88%
cases:2.02%
controls:0.20%
—
—
—
—
cases:4.72%
controls:0.81%
cases:6.93%
controls:1.92%
26
85
370
3882
27
35
370
3939
8
8
389
3966
—
—
18
32
363
3905
25
72
336
3682
Monocytes [#/volume] in Blood
26484-6 [3001604]
8.3e-01
1.4e+00
2.2e+00
—
2.3e+00
1.7e+00
1.0e+00
cases:4.80%
controls:2.14%
cases:5.54%
controls:1.41%
cases:2.52%
controls:0.28%
—
—
cases:2.54%
controls:0.25%
cases:6.82%
controls:1.30%
cases:13.57%
controls:5.35%
19
85
377
3882
22
56
375
3918
10
11
387
3963
—
10
10
384
3961
26
51
355
3886
49
201
312
3553
Basophils [#/volume] in Blood
26444-0 [3006315]
8.3e-01
1.4e+00
2.2e+00
—
2.3e+00
1.7e+00
1.0e+00
cases:4.80%
controls:2.14%
cases:5.54%
controls:1.43%
cases:2.52%
controls:0.28%
—
—
cases:2.54%
controls:0.25%
cases:6.82%
controls:1.30%
cases:13.85%
controls:5.41%
19
85
377
3882
22
57
375
3917
10
11
387
3963
—
10
10
384
3961
26
51
355
3886
50
203
311
3551
Normoblasts [#/volume] in Blood
715-3 [3021589]
7.1e-01
1.5e+00
2.4e+00
—
2.2e+00
1.4e+00
1.2e+00
cases:3.54%
controls:1.76%
cases:5.04%
controls:1.13%
cases:3.27%
controls:0.30%
—
—
cases:2.79%
controls:0.33%
cases:5.51%
controls:1.37%
cases:12.19%
controls:4.18%
14
70
382
3897
20
45
377
3929
13
12
384
3962
—
11
13
383
3958
21
54
360
3883
44
157
317
3597
Internal Medicine
11 [38004456]
7.7e-01
1.4e+00
2.2e+00
—
2.0e+00
1.4e+00
9.6e-01
cases:36.62%
controls:21.17%
cases:29.22%
controls:8.96%
cases:10.08%
controls:1.26%
—
—
cases:11.42%
controls:1.74%
cases:27.82%
controls:9.07%
cases:42.38%
controls:22.06%
145
840
251
3127
116
356
281
3618
40
50
357
3924
—
45
69
349
3902
106
357
275
3580
153
828
208
2926
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
7.6e-01
1.3e+00
2.2e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:4.55%
controls:2.17%
cases:5.04%
controls:1.36%
cases:2.77%
controls:0.33%
—
—
cases:2.79%
controls:0.30%
cases:6.56%
controls:1.24%
cases:13.02%
controls:4.85%
18
86
378
3881
20
54
377
3920
11
13
386
3961
—
11
12
383
3959
25
49
356
3888
47
182
314
3572
Otolaryngology
4 [38004449]
6.3e-01
1.0e+00
2.4e+00
1.0e+50
2.3e+00
1.2e+00
1.0e+00
cases:14.14%
controls:8.09%
cases:8.06%
controls:2.99%
cases:5.54%
controls:0.53%
cases:5.29%
controls:0.00%
cases:3.81%
controls:0.40%
cases:10.50%
controls:3.51%
cases:22.44%
controls:9.38%
56
321
340
3646
32
119
365
3855
22
21
375
3953
21
0
376
3974
15
16
379
3955
40
138
341
3799
81
352
280
3402
fluconazole; oral, parenteral
J02AC01 [21603080]
7.8e-01
1.1e+00
2.0e+00
—
2.5e+00
1.2e+00
9.2e-01
cases:14.90%
controls:7.46%
cases:7.56%
controls:2.62%
cases:1.76%
controls:0.25%
—
—
cases:2.79%
controls:0.23%
cases:8.14%
controls:2.51%
cases:15.79%
controls:6.93%
59
296
337
3671
30
104
367
3870
7
10
390
3964
—
11
9
383
3962
31
99
350
3838
57
260
304
3494
Basophils/Leukocytes in Blood
30180-4 [3022096]
7.8e-01
1.3e+00
2.2e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:4.55%
controls:2.14%
cases:5.04%
controls:1.36%
cases:2.77%
controls:0.33%
—
—
cases:2.79%
controls:0.30%
cases:6.56%
controls:1.24%
cases:12.74%
controls:4.79%
18
85
378
3882
20
54
377
3920
11
13
386
3961
—
11
12
383
3959
25
49
356
3888
46
180
315
3574
Monocytes/Leukocytes in Blood
26485-3 [3019069]
7.6e-01
1.3e+00
2.2e+00
—
2.2e+00
1.7e+00
1.0e+00
cases:4.55%
controls:2.17%
cases:5.04%
controls:1.36%
cases:2.77%
controls:0.33%
—
—
cases:2.79%
controls:0.30%
cases:6.56%
controls:1.24%
cases:12.74%
controls:4.87%
18
86
378
3881
20
54
377
3920
11
13
386
3961
—
11
12
383
3959
25
49
356
3888
46
183
315
3571
Obstetrics / Gynecology
16 [38004461]
5.8e-01
1.4e+00
2.9e+00
—
2.4e+00
1.2e+00
3.5e-01
cases:21.72%
controls:13.46%
cases:18.14%
controls:5.41%
cases:15.11%
controls:1.01%
—
—
cases:10.66%
controls:1.06%
cases:16.01%
controls:5.28%
cases:18.84%
controls:14.09%
86
534
310
3433
72
215
325
3759
60
40
337
3934
—
42
42
352
3929
61
208
320
3729
68
529
293
3225
Eosinophils [#/volume] in Blood
26449-9 [3013115]
7.7e-01
1.4e+00
2.1e+00
—
2.2e+00
1.7e+00
9.8e-01
cases:5.05%
controls:2.39%
cases:5.79%
controls:1.51%
cases:2.77%
controls:0.35%
—
—
cases:2.79%
controls:0.30%
cases:7.35%
controls:1.40%
cases:13.85%
controls:5.70%
20
95
376
3872
23
60
374
3914
11
14
386
3960
—
11
12
383
3959
28
55
353
3882
50
214
311
3540
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
7.4e-01
1.3e+00
2.1e+00
—
2.2e+00
1.6e+00
9.7e-01
cases:4.55%
controls:2.22%
cases:5.04%
controls:1.38%
cases:2.52%
controls:0.30%
—
—
cases:2.54%
controls:0.28%
cases:6.30%
controls:1.32%
cases:12.74%
controls:5.22%
18
88
378
3879
20
55
377
3919
10
12
387
3962
—
10
11
384
3960
24
52
357
3885
46
196
315
3558
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
6.1e-01
1.3e+00
2.1e+00
—
2.2e+00
1.6e+00
1.0e+00
cases:4.04%
controls:2.24%
cases:5.04%
controls:1.38%
cases:2.52%
controls:0.33%
—
—
cases:2.79%
controls:0.30%
cases:6.04%
controls:1.27%
cases:13.02%
controls:5.03%
16
89
380
3878
20
55
377
3919
10
13
387
3961
—
11
12
383
3959
23
50
358
3887
47
189
314
3565
Physiotherapy
R4110 [2001310233]
1.1e+00
1.7e+00
2.3e+00
1.0e+50
—
1.6e+00
1.3e+00
cases:7.32%
controls:2.65%
cases:5.54%
controls:1.06%
cases:2.27%
controls:0.23%
cases:2.52%
controls:0.00%
—
—
cases:5.25%
controls:1.14%
cases:10.25%
controls:2.93%
29
105
367
3862
22
42
375
3932
9
9
388
3965
10
0
387
3974
—
20
45
361
3892
37
110
324
3644
oxycodone; oral, parenteral
N02AA05 [21604260]
1.8e+00
2.3e+00
—
—
—
2.2e+00
1.6e+00
cases:2.27%
controls:0.38%
cases:2.02%
controls:0.20%
—
—
—
—
—
—
cases:2.89%
controls:0.33%
cases:4.99%
controls:1.01%
9
15
387
3952
8
8
389
3966
—
—
—
11
13
370
3924
18
38
343
3716
Cardiology
6 [38004451]
4.1e-01
1.5e+00
1.9e+00
—
1.9e+00
1.5e+00
9.4e-01
cases:8.08%
controls:5.50%
cases:9.57%
controls:2.24%
cases:2.27%
controls:0.35%
—
—
cases:2.03%
controls:0.30%
cases:8.40%
controls:1.96%
cases:17.17%
controls:7.51%
32
218
364
3749
38
89
359
3885
9
14
388
3960
—
8
12
386
3959
32
77
349
3860
62
282
299
3472
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.4e+00
2.5e+00
—
—
—
2.4e+00
1.5e+00
cases:5.30%
controls:1.41%
cases:4.79%
controls:0.40%
—
—
—
—
—
—
cases:4.99%
controls:0.48%
cases:8.31%
controls:2.05%
21
56
375
3911
19
16
378
3958
—
—
—
19
19
362
3918
30
77
331
3677
Abdominal ultrasound examination
JN3AE [2001305555]
1.4e+00
2.0e+00
—
—
—
2.5e+00
1.8e+00
cases:2.53%
controls:0.66%
cases:2.27%
controls:0.30%
—
—
—
—
—
—
cases:3.15%
controls:0.25%
cases:7.20%
controls:1.31%
10
26
386
3941
9
12
388
3962
—
—
—
12
10
369
3927
26
49
335
3705
Urology
34 [38004474]
7.5e-01
9.9e-01
2.6e+00
—
1.9e+00
1.6e+00
6.8e-01
cases:5.81%
controls:2.82%
cases:4.28%
controls:1.64%
cases:2.27%
controls:0.18%
—
—
cases:1.78%
controls:0.28%
cases:6.30%
controls:1.40%
cases:8.86%
controls:4.71%
23
112
373
3855
17
65
380
3909
9
7
388
3967
—
7
11
387
3960
24
55
357
3882
32
177
329
3577
Plastic And Reconstructive Surgery
24 [38004467]
1.3e+00
2.3e+00
—
1.0e+50
—
2.4e+00
1.7e+00
cases:4.29%
controls:1.18%
cases:6.55%
controls:0.73%
—
—
cases:4.28%
controls:0.00%
—
—
cases:7.09%
controls:0.69%
cases:10.80%
controls:2.26%
17
47
379
3920
26
29
371
3945
—
17
0
380
3974
—
27
27
354
3910
39
85
322
3669
General Practice
1 [38004446]
5.0e-01
1.4e+00
1.9e+00
1.0e+50
2.5e+00
1.2e+00
6.8e-01
cases:12.88%
controls:8.19%
cases:13.60%
controls:3.90%
cases:4.28%
controls:0.68%
cases:5.29%
controls:0.00%
cases:6.60%
controls:0.55%
cases:11.29%
controls:3.81%
cases:22.44%
controls:12.79%
51
325
345
3642
54
155
343
3819
17
27
380
3947
21
0
376
3974
26
22
368
3949
43
150
338
3787
81
480
280
3274
Bacteria identified in Blood by Culture
600-7 [3023368]
1.0e+00
2.0e+00
2.5e+00
—
1.0e+50
1.8e+00
1.3e+00
cases:1.77%
controls:0.66%
cases:3.27%
controls:0.48%
cases:1.51%
controls:0.13%
—
—
cases:1.78%
controls:0.00%
cases:2.10%
controls:0.36%
cases:8.31%
controls:2.34%
7
26
389
3941
13
19
384
3955
6
5
391
3969
—
7
0
387
3971
8
14
373
3923
30
88
331
3666
Intravenous general anesthesia
WX404 [2001310807]
1.5e+00
2.6e+00
—
1.0e+50
—
2.0e+00
1.4e+00
cases:5.05%
controls:1.13%
cases:5.54%
controls:0.45%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.94%
controls:0.56%
cases:7.76%
controls:2.02%
20
45
376
3922
22
18
375
3956
—
6
0
391
3974
—
15
22
366
3915
28
76
333
3678
Atherosclerosis of arteries of extremities
I70.2 [45538421]
5.8e-01
1.7e+00
—
1.0e+50
2.7e+00
1.7e+00
1.3e+00
cases:1.52%
controls:0.86%
cases:2.52%
controls:0.48%
—
—
cases:1.51%
controls:0.00%
cases:2.28%
controls:0.15%
cases:3.41%
controls:0.66%
cases:4.71%
controls:1.33%
6
34
390
3933
10
19
387
3955
—
6
0
391
3974
9
6
385
3965
13
26
368
3911
17
50
344
3704
prednisolone
A07EA01 [21600653]
9.0e-01
1.2e+00
1.4e+00
—
1.5e+00
1.4e+00
9.8e-01
cases:15.15%
controls:6.76%
cases:10.83%
controls:3.47%
cases:2.52%
controls:0.63%
—
—
cases:2.54%
controls:0.60%
cases:11.29%
controls:3.00%
cases:21.61%
controls:9.38%
60
268
336
3699
43
138
354
3836
10
25
387
3949
—
10
24
384
3947
43
118
338
3819
78
352
283
3402
Rheumatology
66 [38004491]
1.1e+00
1.6e+00
2.3e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:5.56%
controls:2.02%
cases:5.04%
controls:1.11%
cases:1.76%
controls:0.18%
—
—
cases:1.27%
controls:0.28%
cases:4.20%
controls:1.17%
cases:8.03%
controls:2.77%
22
80
374
3887
20
44
377
3930
7
7
390
3967
—
5
11
389
3960
16
46
365
3891
29
104
332
3650
prednisolone; oral, parenteral
H02AB06 [21602734]
8.9e-01
1.2e+00
1.4e+00
—
1.5e+00
1.4e+00
9.8e-01
cases:14.90%
controls:6.68%
cases:10.83%
controls:3.47%
cases:2.52%
controls:0.63%
—
—
cases:2.54%
controls:0.60%
cases:11.02%
controls:3.00%
cases:21.61%
controls:9.38%
59
265
337
3702
43
138
354
3836
10
25
387
3949
—
10
24
384
3947
42
118
339
3819
78
352
283
3402
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.1e+00
1.4e+00
2.5e+00
—
—
1.4e+00
1.0e+00
cases:6.31%
controls:2.29%
cases:3.78%
controls:1.01%
cases:1.76%
controls:0.15%
—
—
—
—
cases:3.15%
controls:0.79%
cases:4.99%
controls:1.81%
25
91
371
3876
15
40
382
3934
7
6
390
3968
—
—
12
31
369
3906
18
68
343
3686
General anesthesia, balanced
WX408 [2001310808]
9.5e-01
2.3e+00
—
1.0e+50
—
2.6e+00
1.5e+00
cases:5.05%
controls:2.02%
cases:6.80%
controls:0.75%
—
—
cases:2.52%
controls:0.00%
—
—
cases:4.46%
controls:0.36%
cases:9.70%
controls:2.32%
20
80
376
3887
27
30
370
3944
—
10
0
387
3974
—
17
14
364
3923
35
87
326
3667
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.2e-01
1.2e+00
1.8e+00
—
1.7e+00
1.5e+00
9.2e-01
cases:4.04%
controls:2.45%
cases:6.05%
controls:1.89%
cases:2.77%
controls:0.48%
—
—
cases:2.79%
controls:0.50%
cases:7.09%
controls:1.73%
cases:14.40%
controls:6.26%
16
97
380
3870
24
75
373
3899
11
19
386
3955
—
11
20
383
3951
27
68
354
3869
52
235
309
3519
INR in Blood by Coagulation assay
34714-6 [3032080]
5.9e-01
8.0e-01
2.3e+00
—
2.3e+00
1.3e+00
1.0e+00
cases:2.53%
controls:1.41%
cases:2.27%
controls:1.03%
cases:3.27%
controls:0.33%
—
—
cases:3.30%
controls:0.35%
cases:4.72%
controls:1.30%
cases:12.74%
controls:5.06%
10
56
386
3911
9
41
388
3933
13
13
384
3961
—
13
14
381
3957
18
51
363
3886
46
190
315
3564
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
6.8e-01
1.8e+00
—
—
2.2e+00
1.1e+00
1.2e+00
cases:8.84%
controls:4.69%
cases:7.05%
controls:1.26%
—
—
—
—
cases:1.52%
controls:0.18%
cases:4.99%
controls:1.78%
cases:19.67%
controls:7.19%
35
186
361
3781
28
50
369
3924
—
—
6
7
388
3964
19
70
362
3867
71
270
290
3484
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.2e+00
2.7e+00
—
1.0e+50
—
2.7e+00
1.4e+00
cases:3.03%
controls:0.93%
cases:4.03%
controls:0.28%
—
—
cases:2.27%
controls:0.00%
—
—
cases:2.89%
controls:0.20%
cases:4.71%
controls:1.17%
12
37
384
3930
16
11
381
3963
—
9
0
388
3974
—
11
8
370
3929
17
44
344
3710
Neurology
13 [38004458]
7.5e-01
8.3e-01
1.7e+00
1.0e+50
1.5e+00
1.2e+00
8.8e-01
cases:14.90%
controls:7.64%
cases:7.81%
controls:3.55%
cases:3.02%
controls:0.55%
cases:3.02%
controls:0.00%
cases:2.79%
controls:0.65%
cases:9.97%
controls:3.38%
cases:18.84%
controls:8.76%
59
303
337
3664
31
141
366
3833
12
22
385
3952
12
0
385
3974
11
26
383
3945
38
133
343
3804
68
329
293
3425
valaciclovir; oral
J05AB11 [21603137]
1.4e+00
1.8e+00
—
—
—
2.6e+00
1.1e+00
cases:3.03%
controls:0.78%
cases:2.02%
controls:0.35%
—
—
—
—
—
—
cases:2.62%
controls:0.20%
cases:3.88%
controls:1.39%
12
31
384
3936
8
14
389
3960
—
—
—
10
8
371
3929
14
52
347
3702
Essential (primary) hypertension
I10 [45591453]
2.0e-01
1.0e+00
2.3e+00
—
1.6e+00
9.6e-01
7.4e-01
cases:11.11%
controls:9.30%
cases:11.08%
controls:4.23%
cases:4.79%
controls:0.48%
—
—
cases:4.06%
controls:0.88%
cases:12.07%
controls:5.00%
cases:26.87%
controls:14.86%
44
369
352
3598
44
168
353
3806
19
19
378
3955
—
16
35
378
3936
46
197
335
3740
97
558
264
3196
Extensive body CT
JN4BD [2001310899]
1.3e+00
2.5e+00
—
—
—
2.5e+00
1.6e+00
cases:1.77%
controls:0.50%
cases:2.02%
controls:0.18%
—
—
—
—
—
—
cases:1.57%
controls:0.13%
cases:3.32%
controls:0.69%
7
20
389
3947
8
7
389
3967
—
—
—
6
5
375
3932
12
26
349
3728
Laboratory Visit
OMOP4822461 [32036]
7.1e-02
2.8e-01
1.3e+00
3.8e+00
1.4e+00
4.0e-01
1.3e-01
cases:9.60%
controls:9.00%
cases:12.85%
controls:10.07%
cases:10.08%
controls:2.97%
cases:6.55%
controls:0.15%
cases:11.68%
controls:3.10%
cases:16.27%
controls:11.48%
cases:31.86%
controls:29.06%
38
357
358
3610
51
400
346
3574
40
118
357
3856
26
6
371
3968
46
123
348
3848
62
452
319
3485
115
1091
246
2663
Laceration/cut
S18 [2002000983]
3.5e-01
1.5e+00
—
—
2.6e+00
1.4e+00
1.0e+00
cases:2.78%
controls:1.97%
cases:3.53%
controls:0.78%
—
—
—
—
cases:2.54%
controls:0.20%
cases:3.67%
controls:0.91%
cases:12.47%
controls:4.79%
11
78
385
3889
14
31
383
3943
—
—
10
8
384
3963
14
36
367
3901
45
180
316
3574
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
7.2e-01
9.3e-01
2.0e+00
—
2.1e+00
9.5e-01
5.7e-01
cases:6.31%
controls:3.18%
cases:5.79%
controls:2.37%
cases:2.52%
controls:0.35%
—
—
cases:1.78%
controls:0.23%
cases:6.56%
controls:2.64%
cases:18.01%
controls:11.03%
25
126
371
3841
23
94
374
3880
10
14
387
3960
—
7
9
387
3962
25
104
356
3833
65
414
296
3340
Neurosurgery
14 [38004459]
1.1e+00
1.7e+00
—
1.0e+50
—
2.2e+00
1.6e+00
cases:4.04%
controls:1.44%
cases:3.02%
controls:0.55%
—
—
cases:1.26%
controls:0.00%
—
—
cases:4.46%
controls:0.53%
cases:7.48%
controls:1.68%
16
57
380
3910
12
22
385
3952
—
5
0
392
3974
—
17
21
364
3916
27
63
334
3691
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.9e-01
7.3e-01
2.1e+00
—
2.3e+00
8.9e-01
4.9e-01
cases:7.83%
controls:5.95%
cases:9.07%
controls:4.58%
cases:6.55%
controls:0.83%
—
—
cases:7.61%
controls:0.86%
cases:11.81%
controls:5.21%
cases:26.04%
controls:17.71%
31
236
365
3731
36
182
361
3792
26
33
371
3941
—
30
34
364
3937
45
205
336
3732
94
665
267
3089
Nephrology
39 [38004479]
1.5e+00
2.6e+00
—
1.0e+50
—
2.0e+00
1.9e+00
cases:1.77%
controls:0.40%
cases:2.77%
controls:0.20%
—
—
cases:1.76%
controls:0.00%
—
—
cases:2.62%
controls:0.38%
cases:3.88%
controls:0.61%
7
16
389
3951
11
8
386
3966
—
7
0
390
3974
—
10
15
371
3922
14
23
347
3731
Other primary gonarthrosis
M17.1 [45596493]
1.0e+00
1.4e+00
2.5e+00
—
—
1.5e+00
6.6e-01
cases:4.55%
controls:1.71%
cases:3.02%
controls:0.75%
cases:1.51%
controls:0.13%
—
—
—
—
cases:3.15%
controls:0.74%
cases:4.99%
controls:2.64%
18
68
378
3899
12
30
385
3944
6
5
391
3969
—
—
12
29
369
3908
18
99
343
3655
Oral Surgery
19 [38004464]
1.4e+00
2.0e+00
1.0e+50
1.0e+50
—
2.1e+00
2.2e+00
cases:1.52%
controls:0.38%
cases:1.51%
controls:0.20%
cases:1.26%
controls:0.00%
cases:1.51%
controls:0.00%
—
—
cases:1.57%
controls:0.20%
cases:4.99%
controls:0.59%
6
15
390
3952
6
8
391
3966
5
0
392
3974
6
0
391
3974
—
6
8
375
3929
18
22
343
3732
Pharmacy visit
OMOP4822462 [581458]
7.6e-01
1.0e+00
1.2e+00
1.7e+00
1.3e+00
1.0e+00
4.3e-01
cases:96.46%
controls:92.71%
cases:91.94%
controls:80.42%
cases:66.75%
controls:38.55%
cases:9.57%
controls:1.84%
cases:68.53%
controls:37.40%
cases:92.65%
controls:81.76%
cases:97.23%
controls:95.82%
382
3678
14
289
365
3196
32
778
265
1532
132
2442
38
73
359
3901
270
1485
124
2486
353
3219
28
718
351
3597
10
157
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
—
2.3e+00
—
—
—
2.5e+00
1.4e+00
—
—
cases:1.51%
controls:0.15%
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:3.60%
controls:0.91%
—
6
6
391
3968
—
—
—
7
6
374
3931
13
34
348
3720
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
2.3e+00
—
—
—
2.5e+00
1.4e+00
—
—
cases:1.51%
controls:0.15%
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:3.60%
controls:0.91%
—
6
6
391
3968
—
—
—
7
6
374
3931
13
34
348
3720
Physical Medicine And Rehabilitation
25 [38004468]
8.6e-01
1.2e+00
1.1e+00
—
1.8e+00
1.6e+00
8.5e-01
cases:9.34%
controls:4.18%
cases:6.30%
controls:2.04%
cases:1.26%
controls:0.40%
—
—
cases:2.03%
controls:0.35%
cases:8.14%
controls:1.83%
cases:13.57%
controls:6.31%
37
166
359
3801
25
81
372
3893
5
16
392
3958
—
8
14
386
3957
31
72
350
3865
49
237
312
3517
More than one and less than three hours
ZXE10 [2001311401]
9.5e-01
2.0e+00
—
1.0e+50
—
1.8e+00
1.4e+00
cases:10.35%
controls:4.26%
cases:9.82%
controls:1.38%
—
—
cases:4.03%
controls:0.00%
—
—
cases:6.56%
controls:1.14%
cases:16.90%
controls:4.98%
41
169
355
3798
39
55
358
3919
—
16
0
381
3974
—
25
45
356
3892
61
187
300
3567
More than three and less than five hours
ZXE20 [2001311408]
9.3e-01
2.3e+00
—
—
—
2.3e+00
1.5e+00
cases:2.53%
controls:1.01%
cases:3.53%
controls:0.35%
—
—
—
—
—
—
cases:2.89%
controls:0.30%
cases:5.82%
controls:1.39%
10
40
386
3927
14
14
383
3960
—
—
—
11
12
370
3925
21
52
340
3702
epinephrine; parenteral
C01CA24 [21600303]
1.6e+00
1.2e+00
—
—
—
2.5e+00
1.9e+00
cases:2.78%
controls:0.58%
cases:1.26%
controls:0.38%
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:4.16%
controls:0.61%
11
23
385
3944
5
15
392
3959
—
—
—
7
6
374
3931
15
23
346
3731
epinephrine
S01EA01 [21603673]
1.6e+00
1.2e+00
—
—
—
2.5e+00
1.9e+00
cases:2.78%
controls:0.58%
cases:1.26%
controls:0.38%
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:4.16%
controls:0.61%
11
23
385
3944
5
15
392
3959
—
—
—
7
6
374
3931
15
23
346
3731
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
2.6e-01
1.5e+00
1.8e+00
—
2.3e+00
1.1e+00
1.0e+00
cases:2.02%
controls:1.56%
cases:5.04%
controls:1.16%
cases:1.26%
controls:0.20%
—
—
cases:1.78%
controls:0.18%
cases:3.41%
controls:1.12%
cases:11.91%
controls:4.53%
8
62
388
3905
20
46
377
3928
5
8
392
3966
—
7
7
387
3964
13
44
368
3893
43
170
318
3584
Coloscopy
UJF32 [2001305029]
1.1e+00
1.9e+00
—
—
—
1.9e+00
1.2e+00
cases:6.31%
controls:2.17%
cases:4.28%
controls:0.68%
—
—
—
—
—
—
cases:3.94%
controls:0.64%
cases:9.42%
controls:3.12%
25
86
371
3881
17
27
380
3947
—
—
—
15
25
366
3912
34
117
327
3637
furosemide; oral, parenteral
C03CA01 [21601518]
9.4e-01
1.2e+00
1.2e+00
—
1.2e+00
1.4e+00
1.2e+00
cases:9.34%
controls:3.86%
cases:10.58%
controls:3.32%
cases:3.27%
controls:0.98%
—
—
cases:2.54%
controls:0.78%
cases:12.86%
controls:3.68%
cases:18.01%
controls:6.26%
37
153
359
3814
42
132
355
3842
13
39
384
3935
—
10
31
384
3940
49
145
332
3792
65
235
296
3519
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
—
2.2e+00
—
—
—
2.4e+00
1.4e+00
—
—
cases:1.51%
controls:0.18%
—
—
—
—
—
—
cases:1.84%
controls:0.18%
cases:4.43%
controls:1.12%
—
6
7
391
3967
—
—
—
7
7
374
3930
16
42
345
3712
Emergency Medicine
93 [38004510]
5.1e-01
1.0e+00
2.4e+00
—
1.8e+00
8.3e-01
6.3e-01
cases:4.55%
controls:2.77%
cases:3.53%
controls:1.28%
cases:3.02%
controls:0.28%
—
—
cases:2.28%
controls:0.38%
cases:3.94%
controls:1.75%
cases:14.40%
controls:8.26%
18
110
378
3857
14
51
383
3923
12
11
385
3963
—
9
15
385
3956
15
69
366
3868
52
310
309
3444
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
5.0e-01
6.4e-01
1.3e+00
—
1.8e+00
8.1e-01
6.5e-01
cases:24.49%
controls:16.41%
cases:16.88%
controls:9.66%
cases:4.79%
controls:1.41%
—
—
cases:8.88%
controls:1.56%
cases:19.69%
controls:9.83%
cases:43.21%
controls:28.53%
97
651
299
3316
67
384
330
3590
19
56
378
3918
—
35
62
359
3909
75
387
306
3550
156
1071
205
2683
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.1e-01
8.2e-01
1.1e+00
—
1.3e+00
9.2e-01
8.5e-01
cases:14.90%
controls:8.67%
cases:11.59%
controls:5.44%
cases:4.03%
controls:1.36%
—
—
cases:3.81%
controls:1.06%
cases:12.86%
controls:5.54%
cases:28.53%
controls:14.60%
59
344
337
3623
46
216
351
3758
16
54
381
3920
—
15
42
379
3929
49
218
332
3719
103
548
258
3206
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.7e-01
6.6e-01
1.6e+00
—
2.1e+00
1.0e+00
8.6e-01
cases:5.30%
controls:3.38%
cases:5.54%
controls:2.94%
cases:2.77%
controls:0.55%
—
—
cases:3.55%
controls:0.45%
cases:7.35%
controls:2.77%
cases:21.33%
controls:10.34%
21
134
375
3833
22
117
375
3857
11
22
386
3952
—
14
18
380
3953
28
109
353
3828
77
388
284
3366
Hematology
82 [38004501]
1.5e+00
1.8e+00
—
—
—
1.9e+00
1.8e+00
cases:1.52%
controls:0.35%
cases:2.02%
controls:0.33%
—
—
—
—
—
—
cases:2.10%
controls:0.33%
cases:3.32%
controls:0.59%
6
14
390
3953
8
13
389
3961
—
—
—
8
13
373
3924
12
22
349
3732
Case Management Agency
251B00000X [38004193]
4.4e-01
4.2e-01
7.0e-01
2.5e+00
8.7e-01
4.9e-01
3.3e-01
cases:41.92%
controls:31.79%
cases:36.27%
controls:27.28%
cases:15.87%
controls:8.56%
cases:6.55%
controls:0.55%
cases:19.54%
controls:9.27%
cases:41.21%
controls:30.02%
cases:63.71%
controls:55.86%
166
1261
230
2706
144
1084
253
2890
63
340
334
3634
26
22
371
3952
77
368
317
3603
157
1182
224
2755
230
2097
131
1657
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.0e+00
1.5e+00
—
—
—
1.6e+00
1.3e+00
cases:6.82%
controls:2.62%
cases:3.78%
controls:0.86%
—
—
—
—
—
—
cases:4.20%
controls:0.86%
cases:11.91%
controls:3.54%
27
104
369
3863
15
34
382
3940
—
—
—
16
34
365
3903
43
133
318
3621
clindamycin; oral, parenteral
J01FF01 [21602985]
9.1e-01
1.9e+00
—
—
—
1.6e+00
1.0e+00
cases:7.58%
controls:3.20%
cases:4.28%
controls:0.65%
—
—
—
—
—
—
cases:4.20%
controls:0.91%
cases:8.03%
controls:3.09%
30
127
366
3840
17
26
380
3948
—
—
—
16
36
365
3901
29
116
332
3638
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
8.3e-01
2.0e+00
—
—
—
1.8e+00
1.5e+00
cases:1.26%
controls:0.55%
cases:2.27%
controls:0.30%
—
—
—
—
—
—
cases:1.84%
controls:0.30%
cases:2.49%
controls:0.59%
5
22
391
3945
9
12
388
3962
—
—
—
7
12
374
3925
9
22
352
3732
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
9.9e-01
1.7e+00
1.9e+00
—
—
1.5e+00
1.1e+00
cases:12.88%
controls:5.19%
cases:8.82%
controls:1.81%
cases:1.51%
controls:0.23%
—
—
—
—
cases:7.87%
controls:1.91%
cases:16.90%
controls:6.23%
51
206
345
3761
35
72
362
3902
6
9
391
3965
—
—
30
75
351
3862
61
234
300
3520
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.7e+00
2.9e+00
—
—
—
—
2.3e+00
cases:1.26%
controls:0.23%
cases:2.77%
controls:0.15%
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.35%
5
9
391
3958
11
6
386
3968
—
—
—
—
12
13
349
3741
Atherosclerotic heart disease
I25.1 [45596196]
1.6e-01
1.6e+00
—
1.0e+50
2.4e+00
1.1e+00
5.7e-01
cases:3.28%
controls:2.82%
cases:5.79%
controls:1.21%
—
—
cases:2.02%
controls:0.00%
cases:2.28%
controls:0.20%
cases:4.99%
controls:1.68%
cases:7.76%
controls:4.53%
13
112
383
3855
23
48
374
3926
—
8
0
389
3974
9
8
385
3963
19
66
362
3871
28
170
333
3584
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
9.5e-01
1.6e+00
—
—
—
1.7e+00
9.6e-01
cases:5.56%
controls:2.22%
cases:3.53%
controls:0.73%
—
—
—
—
—
—
cases:3.41%
controls:0.66%
cases:5.82%
controls:2.32%
22
88
374
3879
14
29
383
3945
—
—
—
13
26
368
3911
21
87
340
3667
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
1.3e+00
1.8e+00
—
—
—
1.8e+00
1.5e+00
cases:2.27%
controls:0.60%
cases:2.02%
controls:0.33%
—
—
—
—
—
—
cases:2.10%
controls:0.36%
cases:6.37%
controls:1.49%
9
24
387
3943
8
13
389
3961
—
—
—
8
14
373
3923
23
56
338
3698
Supplier / Service Provider
OMOP5117446 [33004]
-1.4e+00
-3.1e-01
—
—
1.0e+50
2.8e+00
3.7e+00
cases:7.07%
controls:23.92%
cases:4.79%
controls:6.44%
—
—
—
—
cases:1.78%
controls:0.00%
cases:4.20%
controls:0.25%
cases:15.79%
controls:0.48%
28
949
368
3018
19
256
378
3718
—
—
7
0
387
3971
16
10
365
3927
57
18
304
3736
Vascular Surgery
77 [38004496]
5.4e-01
1.7e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:1.77%
controls:1.03%
cases:4.03%
controls:0.73%
—
—
cases:1.76%
controls:0.00%
—
—
cases:3.41%
controls:0.51%
cases:8.03%
controls:2.29%
7
41
389
3926
16
29
381
3945
—
7
0
390
3974
—
13
20
368
3917
29
86
332
3668
duloxetine; oral
N06AX21 [21604749]
1.3e+00
1.9e+00
—
—
—
1.7e+00
1.0e+00
cases:2.78%
controls:0.76%
cases:2.02%
controls:0.30%
—
—
—
—
—
—
cases:2.10%
controls:0.38%
cases:3.60%
controls:1.33%
11
30
385
3937
8
12
389
3962
—
—
—
8
15
373
3922
13
50
348
3704
Psychiatry
26 [38004469]
1.1e+00
8.7e-01
1.6e+00
—
1.3e+00
1.2e+00
1.0e+00
cases:9.85%
controls:3.53%
cases:4.28%
controls:1.84%
cases:3.53%
controls:0.70%
—
—
cases:2.79%
controls:0.81%
cases:5.51%
controls:1.70%
cases:11.63%
controls:4.61%
39
140
357
3827
17
73
380
3901
14
28
383
3946
—
11
32
383
3939
21
67
360
3870
42
173
319
3581
Other and unspecified abdominal pain
R10.4 [45568113]
9.0e-01
1.8e+00
—
—
—
1.4e+00
7.8e-01
cases:8.59%
controls:3.68%
cases:4.79%
controls:0.86%
—
—
—
—
—
—
cases:4.99%
controls:1.24%
cases:9.97%
controls:4.82%
34
146
362
3821
19
34
378
3940
—
—
—
19
49
362
3888
36
181
325
3573
alfacalcidol; oral, parenteral
A11CC03 [21600818]
2.5e+00
—
—
—
—
—
2.4e+00
cases:1.52%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.16%
6
5
390
3962
—
—
—
—
—
6
6
355
3748
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
6.2e-01
1.0e+00
—
—
2.8e+00
6.6e-01
9.7e-01
cases:4.04%
controls:2.22%
cases:3.78%
controls:1.41%
—
—
—
—
cases:2.54%
controls:0.15%
cases:2.10%
controls:1.09%
cases:12.47%
controls:5.11%
16
88
380
3879
15
56
382
3918
—
—
10
6
384
3965
8
43
373
3894
45
192
316
3562
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
6.2e-01
1.0e+00
2.3e+00
—
2.5e+00
9.7e-01
2.5e-01
cases:3.54%
controls:1.94%
cases:2.77%
controls:1.03%
cases:1.76%
controls:0.18%
—
—
cases:1.52%
controls:0.13%
cases:3.41%
controls:1.32%
cases:6.37%
controls:5.03%
14
77
382
3890
11
41
386
3933
7
7
390
3967
—
6
5
388
3966
13
52
368
3885
23
189
338
3565
Left side
ZXA05 [2001311347]
8.3e-01
2.1e+00
—
—
—
1.7e+00
1.0e+00
cases:5.30%
controls:2.39%
cases:4.53%
controls:0.60%
—
—
—
—
—
—
cases:3.67%
controls:0.71%
cases:8.03%
controls:3.12%
21
95
375
3872
18
24
379
3950
—
—
—
14
28
367
3909
29
117
332
3637
CBC panel - Blood by Automated count
58410-2 [40761511]
1.2e-01
5.0e-01
1.9e+00
—
2.2e+00
6.0e-01
4.0e-01
cases:6.82%
controls:6.10%
cases:8.56%
controls:5.36%
cases:5.79%
controls:0.91%
—
—
cases:8.12%
controls:0.96%
cases:11.29%
controls:6.55%
cases:27.15%
controls:20.03%
27
242
369
3725
34
213
363
3761
23
36
374
3938
—
32
38
362
3933
43
258
338
3679
98
752
263
3002
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
8.9e-01
1.8e+00
—
—
—
1.8e+00
1.1e+00
cases:2.78%
controls:1.16%
cases:2.27%
controls:0.38%
—
—
—
—
—
—
cases:1.84%
controls:0.30%
cases:4.43%
controls:1.55%
11
46
385
3921
9
15
388
3959
—
—
—
7
12
374
3925
16
58
345
3696
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.8e-01
6.2e-01
1.9e+00
—
2.1e+00
5.9e-01
4.0e-01
cases:7.58%
controls:5.82%
cases:9.32%
controls:5.26%
cases:6.55%
controls:1.01%
—
—
cases:7.87%
controls:1.01%
cases:11.55%
controls:6.76%
cases:27.42%
controls:20.27%
30
231
366
3736
37
209
360
3765
26
40
371
3934
—
31
40
363
3931
44
266
337
3671
99
761
262
2993
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.5e-01
6.3e-01
1.9e+00
—
2.1e+00
5.9e-01
3.9e-01
cases:7.32%
controls:5.82%
cases:9.32%
controls:5.21%
cases:6.55%
controls:1.01%
—
—
cases:7.61%
controls:0.98%
cases:11.55%
controls:6.76%
cases:27.15%
controls:20.19%
29
231
367
3736
37
207
360
3767
26
40
371
3934
—
30
39
364
3932
44
266
337
3671
98
758
263
2996
FVC percent change Respiratory system
69982-7 [42868471]
1.3e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:2.02%
controls:0.55%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:5.54%
controls:0.48%
8
22
388
3945
5
5
392
3969
—
—
—
7
9
374
3928
20
18
341
3736
FEV1 --post bronchodilation
20155-8 [3023550]
1.3e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:2.02%
controls:0.55%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:5.54%
controls:0.48%
8
22
388
3945
5
5
392
3969
—
—
—
7
9
374
3928
20
18
341
3736
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.3e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:2.02%
controls:0.55%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:5.54%
controls:0.48%
8
22
388
3945
5
5
392
3969
—
—
—
7
9
374
3928
20
18
341
3736
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.3e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:2.02%
controls:0.55%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:5.54%
controls:0.48%
8
22
388
3945
5
5
392
3969
—
—
—
7
9
374
3928
20
18
341
3736
FEV1 percent change
69983-5 [42868472]
1.3e+00
2.3e+00
—
—
—
2.1e+00
2.5e+00
cases:2.02%
controls:0.55%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:5.54%
controls:0.48%
8
22
388
3945
5
5
392
3969
—
—
—
7
9
374
3928
20
18
341
3736
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
2.5e+00
2.3e+00
—
—
—
2.1e+00
1.6e+00
cases:2.78%
controls:0.23%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.57%
controls:0.20%
cases:1.94%
controls:0.40%
11
9
385
3958
5
5
392
3969
—
—
—
6
8
375
3929
7
15
354
3739
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.8e+00
—
—
—
—
—
2.8e+00
cases:1.77%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:4.99%
controls:0.32%
7
12
389
3955
—
—
—
—
—
18
12
343
3742
calcium carbonate; oral
A12AA04 [21600863]
1.9e+00
2.3e+00
—
—
—
2.2e+00
2.4e+00
cases:1.52%
controls:0.23%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.57%
controls:0.18%
cases:1.66%
controls:0.16%
6
9
390
3958
5
5
392
3969
—
—
—
6
7
375
3930
6
6
355
3748
calcium carbonate
A02AC01 [21600065]
1.9e+00
2.3e+00
—
—
—
2.2e+00
2.4e+00
cases:1.52%
controls:0.23%
cases:1.26%
controls:0.13%
—
—
—
—
—
—
cases:1.57%
controls:0.18%
cases:1.66%
controls:0.16%
6
9
390
3958
5
5
392
3969
—
—
—
6
7
375
3930
6
6
355
3748
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.4e-01
8.0e-01
2.4e+00
—
2.1e+00
6.2e-01
3.9e-01
cases:2.78%
controls:2.19%
cases:2.77%
controls:1.26%
cases:2.52%
controls:0.23%
—
—
cases:2.03%
controls:0.25%
cases:2.89%
controls:1.57%
cases:10.53%
controls:7.35%
11
87
385
3880
11
50
386
3924
10
9
387
3965
—
8
10
386
3961
11
62
370
3875
38
276
323
3478
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
1.9e+00
—
—
—
—
—
2.6e+00
cases:2.02%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.77%
controls:0.21%
8
12
388
3955
—
—
—
—
—
10
8
351
3746
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.7e-01
7.5e-01
1.7e+00
—
1.5e+00
5.0e-01
4.8e-01
cases:5.30%
controls:3.73%
cases:6.55%
controls:3.20%
cases:4.53%
controls:0.86%
—
—
cases:3.30%
controls:0.76%
cases:6.56%
controls:4.09%
cases:19.94%
controls:13.32%
21
148
375
3819
26
127
371
3847
18
34
379
3940
—
13
30
381
3941
25
161
356
3776
72
500
289
3254
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
1.4e+00
2.7e+00
1.0e+50
1.0e+50
—
—
1.8e+00
cases:1.26%
controls:0.30%
cases:1.76%
controls:0.13%
cases:3.02%
controls:0.00%
cases:3.78%
controls:0.00%
—
—
—
—
cases:3.05%
controls:0.53%
5
12
391
3955
7
5
390
3969
12
0
385
3974
15
0
382
3974
—
—
11
20
350
3734
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.8e-01
8.3e-01
2.1e+00
—
1.3e+00
1.1e+00
1.2e+00
cases:3.03%
controls:1.71%
cases:2.77%
controls:1.23%
cases:2.02%
controls:0.25%
—
—
cases:1.52%
controls:0.40%
cases:4.46%
controls:1.47%
cases:14.68%
controls:5.03%
12
68
384
3899
11
49
386
3925
8
10
389
3964
—
6
16
388
3955
17
58
364
3879
53
189
308
3565
Dyspnoea
R06.0 [45558449]
5.6e-01
1.4e+00
—
—
—
1.6e+00
1.4e+00
cases:2.78%
controls:1.61%
cases:2.52%
controls:0.65%
—
—
—
—
—
—
cases:2.10%
controls:0.43%
cases:9.70%
controls:2.53%
11
64
385
3903
10
26
387
3948
—
—
—
8
17
373
3920
35
95
326
3659
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
9.7e-01
1.7e+00
—
1.0e+50
—
1.7e+00
6.4e-01
cases:6.82%
controls:2.70%
cases:5.29%
controls:0.98%
—
—
cases:3.02%
controls:0.00%
—
—
cases:4.72%
controls:0.94%
cases:6.37%
controls:3.46%
27
107
369
3860
21
39
376
3935
—
12
0
385
3974
—
18
37
363
3900
23
130
338
3624
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
-1.0e+50
—
—
—
—
2.3e+00
2.0e+00
cases:0.00%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.13%
cases:1.94%
controls:0.27%
0
15
396
3952
—
—
—
—
5
5
376
3932
7
10
354
3744
Other angina pectoris stenosed coronary artery
I20.81 [2000502397]
5.5e-01
2.1e+00
—
—
—
2.2e+00
1.3e+00
cases:1.52%
controls:0.88%
cases:2.27%
controls:0.28%
—
—
—
—
—
—
cases:1.84%
controls:0.20%
cases:2.77%
controls:0.75%
6
35
390
3932
9
11
388
3963
—
—
—
7
8
374
3929
10
28
351
3726
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
—
—
—
—
—
2.4e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:2.10%
controls:0.20%
cases:4.43%
controls:0.64%
—
—
—
—
—
8
8
373
3929
16
24
345
3730
Treatment plan or consultation
WZC00 [2001310885]
8.9e-01
1.6e+00
—
1.0e+50
—
1.6e+00
1.0e+00
cases:4.55%
controls:1.92%
cases:5.04%
controls:1.08%
—
—
cases:1.51%
controls:0.00%
—
—
cases:3.94%
controls:0.79%
cases:9.97%
controls:3.86%
18
76
378
3891
20
43
377
3931
—
6
0
391
3974
—
15
31
366
3906
36
145
325
3609
Sedation and analgesia
WX002 [2001310758]
1.2e+00
1.9e+00
—
—
—
—
1.1e+00
cases:3.03%
controls:0.91%
cases:2.27%
controls:0.35%
—
—
—
—
—
—
—
—
cases:5.82%
controls:1.97%
12
36
384
3931
9
14
388
3960
—
—
—
—
21
74
340
3680
calcium (different salts in combination); oral
A12AA20 [21600872]
5.0e-01
9.6e-01
6.3e-01
—
1.3e+00
9.7e-01
9.5e-01
cases:8.59%
controls:5.39%
cases:10.58%
controls:4.33%
cases:2.02%
controls:1.08%
—
—
cases:2.79%
controls:0.76%
cases:11.81%
controls:4.85%
cases:18.84%
controls:8.26%
34
214
362
3753
42
172
355
3802
8
43
389
3931
—
11
30
383
3941
45
191
336
3746
68
310
293
3444
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.7e-01
7.4e-01
1.7e+00
—
1.8e+00
6.2e-01
6.6e-01
cases:4.04%
controls:3.10%
cases:4.28%
controls:2.09%
cases:2.27%
controls:0.40%
—
—
cases:1.78%
controls:0.30%
cases:4.20%
controls:2.31%
cases:15.79%
controls:8.82%
16
123
380
3844
17
83
380
3891
9
16
388
3958
—
7
12
387
3959
16
91
365
3846
57
331
304
3423
Exposure to unspecified factor
X59 [45756412]
9.6e-01
2.2e+00
—
1.0e+50
—
1.3e+00
1.0e+00
cases:4.29%
controls:1.69%
cases:3.02%
controls:0.35%
—
—
cases:1.26%
controls:0.00%
—
—
cases:2.10%
controls:0.58%
cases:6.09%
controls:2.24%
17
67
379
3900
12
14
385
3960
—
5
0
392
3974
—
8
23
373
3914
22
84
339
3670
esomeprazole; oral, parenteral
A02BC05 [21600100]
7.0e-01
6.6e-01
1.6e+00
—
1.2e+00
1.1e+00
7.5e-01
cases:12.37%
controls:6.53%
cases:6.30%
controls:3.37%
cases:3.02%
controls:0.65%
—
—
cases:2.28%
controls:0.73%
cases:9.19%
controls:3.12%
cases:14.68%
controls:7.54%
49
259
347
3708
25
134
372
3840
12
26
385
3948
—
9
29
385
3942
35
123
346
3814
53
283
308
3471
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.9e+00
1.6e+00
—
—
—
—
2.2e+00
cases:2.02%
controls:0.30%
cases:1.26%
controls:0.25%
—
—
—
—
—
—
—
—
cases:4.43%
controls:0.51%
8
12
388
3955
5
10
392
3964
—
—
—
—
16
19
345
3735
Cathetrisation of vein
TPH04 [2001309597]
1.2e+00
1.7e+00
—
1.0e+50
—
1.2e+00
1.2e+00
cases:4.29%
controls:1.29%
cases:3.02%
controls:0.55%
—
—
cases:1.26%
controls:0.00%
—
—
cases:1.31%
controls:0.41%
cases:5.82%
controls:1.92%
17
51
379
3916
12
22
385
3952
—
5
0
392
3974
—
5
16
376
3921
21
72
340
3682
Bacterial pneumonia, unspecified
J15.9 [45557621]
1.0e+00
2.3e+00
—
—
—
1.7e+00
7.1e-01
cases:1.77%
controls:0.66%
cases:1.76%
controls:0.18%
—
—
—
—
—
—
cases:2.10%
controls:0.38%
cases:1.94%
controls:0.96%
7
26
389
3941
7
7
390
3967
—
—
—
8
15
373
3922
7
36
354
3718
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
7.1e-02
4.7e-01
1.9e+00
—
1.7e+00
5.2e-01
5.3e-01
cases:5.56%
controls:5.19%
cases:7.05%
controls:4.53%
cases:5.79%
controls:0.96%
—
—
cases:5.58%
controls:1.11%
cases:8.66%
controls:5.33%
cases:22.99%
controls:15.00%
22
206
374
3761
28
180
369
3794
23
38
374
3936
—
22
44
372
3927
33
210
348
3727
83
563
278
3191
Bronchiectasis
J47 [45605889]
2.0e+00
2.0e+00
—
—
—
—
2.0e+00
cases:1.52%
controls:0.20%
cases:1.26%
controls:0.18%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.32%
6
8
390
3959
5
7
392
3967
—
—
—
—
8
12
353
3742
Dry eye syndrome
H04.10 [2000502254]
1.7e+00
-1.0e+50
—
—
—
2.5e+00
1.4e+00
cases:1.77%
controls:0.33%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:1.57%
controls:0.13%
cases:2.77%
controls:0.69%
7
13
389
3954
0
6
397
3968
—
—
—
6
5
375
3932
10
26
351
3728
Right side
ZXA00 [2001311346]
9.9e-01
1.8e+00
—
—
—
8.0e-01
1.1e+00
cases:6.82%
controls:2.65%
cases:5.54%
controls:0.93%
—
—
—
—
—
—
cases:1.57%
controls:0.71%
cases:10.25%
controls:3.62%
27
105
369
3862
22
37
375
3937
—
—
—
6
28
375
3909
37
136
324
3618
loperamide; oral
A07DA03 [21600646]
1.0e+00
—
—
—
—
2.5e+00
1.4e+00
cases:1.52%
controls:0.55%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:3.32%
controls:0.83%
6
22
390
3945
—
—
—
—
7
6
374
3931
12
31
349
3723
loperamide oxide; oral
A07DA05 [21600648]
1.0e+00
—
—
—
—
2.5e+00
1.4e+00
cases:1.52%
controls:0.55%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.15%
cases:3.32%
controls:0.83%
6
22
390
3945
—
—
—
—
7
6
374
3931
12
31
349
3723
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
—
2.3e+00
—
—
—
—
1.6e+00
—
—
cases:1.76%
controls:0.18%
—
—
—
—
—
—
—
—
cases:3.60%
controls:0.77%
—
7
7
390
3967
—
—
—
—
13
29
348
3725
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
7.3e-01
1.8e+00
—
—
—
2.1e+00
7.0e-01
cases:2.27%
controls:1.11%
cases:2.27%
controls:0.38%
—
—
—
—
—
—
cases:2.36%
controls:0.30%
cases:3.88%
controls:1.97%
9
44
387
3923
9
15
388
3959
—
—
—
9
12
372
3925
14
74
347
3680
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
5.4e-01
5.1e-01
1.6e+00
—
1.2e+00
3.9e-01
2.8e-01
cases:38.64%
controls:26.87%
cases:18.64%
controls:12.05%
cases:7.81%
controls:1.61%
—
—
cases:5.08%
controls:1.64%
cases:18.11%
controls:13.06%
cases:40.44%
controls:33.86%
153
1066
243
2901
74
479
323
3495
31
64
366
3910
—
20
65
374
3906
69
514
312
3423
146
1271
215
2483
ibuprofen
R02AX02 [1588667]
5.4e-01
5.1e-01
1.6e+00
—
1.2e+00
3.9e-01
2.8e-01
cases:38.64%
controls:26.87%
cases:18.64%
controls:12.05%
cases:7.81%
controls:1.61%
—
—
cases:5.08%
controls:1.64%
cases:18.11%
controls:13.06%
cases:40.44%
controls:33.86%
153
1066
243
2901
74
479
323
3495
31
64
366
3910
—
20
65
374
3906
69
514
312
3423
146
1271
215
2483
Social worker
Z2446 [2001311559]
1.5e+00
2.3e+00
—
—
—
—
1.1e+00
cases:3.03%
controls:0.68%
cases:2.27%
controls:0.23%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.53%
12
27
384
3940
9
9
388
3965
—
—
—
—
6
20
355
3734
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
1.3e+00
2.6e+00
—
—
—
1.3e+00
8.8e-01
cases:3.28%
controls:0.96%
cases:2.27%
controls:0.18%
—
—
—
—
—
—
cases:2.10%
controls:0.56%
cases:4.43%
controls:1.89%
13
38
383
3929
9
7
388
3967
—
—
—
8
22
373
3915
16
71
345
3683
Ultrasound measurement of residual urine
KC1EE [2001305918]
1.5e+00
—
—
—
—
2.3e+00
9.1e-01
cases:2.27%
controls:0.53%
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.13%
cases:3.32%
controls:1.36%
9
21
387
3946
—
—
—
—
5
5
376
3932
12
51
349
3703
enoxaparin; parenteral
B01AB05 [21600976]
1.0e+00
1.2e+00
—
—
—
1.5e+00
1.2e+00
cases:5.81%
controls:2.12%
cases:2.77%
controls:0.83%
—
—
—
—
—
—
cases:3.94%
controls:0.91%
cases:11.36%
controls:3.57%
23
84
373
3883
11
33
386
3941
—
—
—
15
36
366
3901
41
134
320
3620
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.3e-01
4.2e-01
1.8e+00
—
2.0e+00
4.5e-01
2.1e-01
cases:8.84%
controls:7.86%
cases:11.08%
controls:7.55%
cases:8.82%
controls:1.64%
—
—
cases:10.41%
controls:1.54%
cases:13.91%
controls:9.32%
cases:29.36%
controls:25.17%
35
312
361
3655
44
300
353
3674
35
65
362
3909
—
41
61
353
3910
53
367
328
3570
106
945
255
2809
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.2e-01
4.3e-01
1.8e+00
—
2.0e+00
4.6e-01
2.1e-01
cases:8.84%
controls:7.92%
cases:11.08%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.41%
controls:1.56%
cases:13.91%
controls:9.27%
cases:29.36%
controls:25.15%
35
314
361
3653
44
299
353
3675
35
64
362
3910
—
41
62
353
3909
53
365
328
3572
106
944
255
2810
Platelets [#/volume] in Blood
26515-7 [3007461]
1.4e-01
4.3e-01
1.8e+00
—
2.0e+00
4.7e-01
2.1e-01
cases:8.84%
controls:7.76%
cases:11.08%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.15%
controls:1.54%
cases:13.91%
controls:9.19%
cases:29.36%
controls:25.17%
35
308
361
3659
44
299
353
3675
35
64
362
3910
—
40
61
354
3910
53
362
328
3575
106
945
255
2809
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.3e-01
4.3e-01
1.8e+00
—
2.0e+00
4.6e-01
2.1e-01
cases:8.84%
controls:7.81%
cases:11.08%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.15%
controls:1.54%
cases:13.91%
controls:9.27%
cases:29.36%
controls:25.17%
35
310
361
3657
44
299
353
3675
35
64
362
3910
—
40
61
354
3910
53
365
328
3572
106
945
255
2809
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.3e-01
4.3e-01
1.8e+00
—
2.0e+00
4.6e-01
2.1e-01
cases:8.84%
controls:7.81%
cases:11.08%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.15%
controls:1.54%
cases:13.91%
controls:9.27%
cases:29.36%
controls:25.17%
35
310
361
3657
44
299
353
3675
35
64
362
3910
—
40
61
354
3910
53
365
328
3572
106
945
255
2809
MCH [Entitic mass]
28539-5 [3035941]
1.3e-01
4.3e-01
1.8e+00
—
2.0e+00
4.7e-01
2.1e-01
cases:8.84%
controls:7.81%
cases:11.08%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.15%
controls:1.54%
cases:13.91%
controls:9.19%
cases:29.36%
controls:25.17%
35
310
361
3657
44
299
353
3675
35
64
362
3910
—
40
61
354
3910
53
362
328
3575
106
945
255
2809
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.3e-01
4.5e-01
1.8e+00
—
2.0e+00
4.6e-01
2.1e-01
cases:8.84%
controls:7.81%
cases:11.34%
controls:7.52%
cases:8.82%
controls:1.61%
—
—
cases:10.15%
controls:1.54%
cases:13.91%
controls:9.25%
cases:29.36%
controls:25.17%
35
310
361
3657
45
299
352
3675
35
64
362
3910
—
40
61
354
3910
53
364
328
3573
106
945
255
2809
Infiltration anesthesia
WX110 [2001310767]
5.7e-01
1.1e+00
2.0e+00
—
—
4.6e-01
6.0e-01
cases:11.11%
controls:6.58%
cases:9.82%
controls:3.35%
cases:3.27%
controls:0.45%
—
—
—
—
cases:6.04%
controls:3.89%
cases:22.99%
controls:14.09%
44
261
352
3706
39
133
358
3841
13
18
384
3956
—
—
23
153
358
3784
83
529
278
3225
pregabalin; oral
N02BF02 [955152]
8.4e-01
8.4e-01
—
—
1.4e+00
1.5e+00
1.4e+00
cases:5.81%
controls:2.60%
cases:3.53%
controls:1.56%
—
—
—
—
cases:1.78%
controls:0.45%
cases:5.77%
controls:1.35%
cases:11.08%
controls:2.96%
23
103
373
3864
14
62
383
3912
—
—
7
18
387
3953
22
53
359
3884
40
111
321
3643
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.9e-01
5.4e-01
1.8e+00
—
1.9e+00
5.4e-01
3.2e-01
cases:8.08%
controls:6.76%
cases:10.33%
controls:6.32%
cases:7.56%
controls:1.33%
—
—
cases:8.12%
controls:1.26%
cases:12.60%
controls:7.77%
cases:28.81%
controls:22.75%
32
268
364
3699
41
251
356
3723
30
53
367
3921
—
32
50
362
3921
48
306
333
3631
104
854
257
2900
12 lead EKG panel
34534-8 [3044889]
1.6e-01
1.0e+00
2.7e+00
—
—
4.4e-01
4.6e-01
cases:3.28%
controls:2.82%
cases:5.04%
controls:1.91%
cases:2.52%
controls:0.18%
—
—
—
—
cases:3.94%
controls:2.57%
cases:16.34%
controls:10.95%
13
112
383
3855
20
76
377
3898
10
7
387
3967
—
—
15
101
366
3836
59
411
302
3343
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
8.6e-01
1.3e+00
—
—
—
1.4e+00
1.0e+00
cases:3.03%
controls:1.31%
cases:3.78%
controls:1.11%
—
—
—
—
—
—
cases:3.67%
controls:0.97%
cases:11.36%
controls:4.32%
12
52
384
3915
15
44
382
3930
—
—
—
14
38
367
3899
41
162
320
3592
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
1.3e+00
2.3e+00
—
—
—
—
7.7e-01
cases:2.78%
controls:0.76%
cases:2.02%
controls:0.20%
—
—
—
—
—
—
—
—
cases:2.22%
controls:1.04%
11
30
385
3937
8
8
389
3966
—
—
—
—
8
39
353
3715
Supine thorax X-ray examination
GD1QA [2001303648]
—
2.3e+00
—
1.0e+50
—
1.2e+00
1.3e+00
—
—
cases:1.76%
controls:0.18%
—
—
cases:1.26%
controls:0.00%
—
—
cases:1.57%
controls:0.46%
cases:4.43%
controls:1.31%
—
7
7
390
3967
—
5
0
392
3974
—
6
18
375
3919
16
49
345
3705
Respiratory and circulatory monitoring
WX700 [2001310817]
2.7e-01
2.4e+00
—
1.0e+50
—
1.5e+00
1.1e+00
cases:1.77%
controls:1.36%
cases:2.27%
controls:0.20%
—
—
cases:1.76%
controls:0.00%
—
—
cases:2.10%
controls:0.46%
cases:4.43%
controls:1.55%
7
54
389
3913
9
8
388
3966
—
7
0
390
3974
—
8
18
373
3919
16
58
345
3696
moxifloxacin; oral, parenteral
J01MA14 [21603021]
2.1e+00
1.8e+00
—
—
—
—
1.4e+00
cases:2.78%
controls:0.35%
cases:1.51%
controls:0.25%
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.83%
11
14
385
3953
6
10
391
3964
—
—
—
—
12
31
349
3723
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
2.2e+00
—
—
—
—
—
1.3e+00
cases:1.52%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.83%
6
7
390
3960
—
—
—
—
—
11
31
350
3723
triamcinolone and antiinfectives
S02CA04 [21605176]
1.8e+00
—
—
—
—
—
1.6e+00
cases:2.53%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.67%
10
17
386
3950
—
—
—
—
—
12
25
349
3729
Fever, unspecified
R50.9 [45582716]
1.2e+00
2.0e+00
—
—
—
1.2e+00
1.4e+00
cases:2.78%
controls:0.88%
cases:1.51%
controls:0.20%
—
—
—
—
—
—
cases:1.31%
controls:0.38%
cases:4.99%
controls:1.28%
11
35
385
3932
6
8
391
3966
—
—
—
5
15
376
3922
18
48
343
3706
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
7.4e-01
9.4e-01
1.7e+00
—
—
5.8e-01
2.7e-01
cases:15.40%
controls:7.97%
cases:5.29%
controls:2.14%
cases:2.52%
controls:0.45%
—
—
—
—
cases:3.67%
controls:2.08%
cases:6.37%
controls:4.95%
61
316
335
3651
21
85
376
3889
10
18
387
3956
—
—
14
82
367
3855
23
186
338
3568
methotrexate
L01BA01 [21601423]
9.2e-01
1.1e+00
—
—
1.4e+00
1.2e+00
1.1e+00
cases:3.28%
controls:1.34%
cases:3.53%
controls:1.18%
—
—
—
—
cases:1.52%
controls:0.38%
cases:4.20%
controls:1.30%
cases:5.54%
controls:2.00%
13
53
383
3914
14
47
383
3927
—
—
6
15
388
3956
16
51
365
3886
20
75
341
3679
methotrexate; oral, parenteral
L04AX03 [21603929]
9.2e-01
1.1e+00
—
—
1.4e+00
1.2e+00
1.1e+00
cases:3.28%
controls:1.34%
cases:3.53%
controls:1.18%
—
—
—
—
cases:1.52%
controls:0.38%
cases:4.20%
controls:1.30%
cases:5.54%
controls:2.00%
13
53
383
3914
14
47
383
3927
—
—
6
15
388
3956
16
51
365
3886
20
75
341
3679
allopurinol; oral, parenteral
M04AA01 [21604131]
1.1e+00
1.3e+00
—
—
—
1.2e+00
9.6e-01
cases:4.04%
controls:1.41%
cases:3.27%
controls:0.88%
—
—
—
—
—
—
cases:3.15%
controls:0.97%
cases:4.99%
controls:1.97%
16
56
380
3911
13
35
384
3939
—
—
—
12
38
369
3899
18
74
343
3680
Epistaxis
R04.0 [45606791]
1.8e+00
—
—
—
—
—
1.6e+00
cases:2.02%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.45%
8
14
388
3953
—
—
—
—
—
8
17
353
3737
methylprednisolone; oral, parenteral
H02AB04 [21602732]
3.6e-01
9.6e-01
—
—
2.3e+00
1.3e+00
1.0e+00
cases:3.54%
controls:2.50%
cases:2.02%
controls:0.78%
—
—
—
—
cases:1.52%
controls:0.15%
cases:2.62%
controls:0.74%
cases:4.99%
controls:1.84%
14
99
382
3868
8
31
389
3943
—
—
6
6
388
3965
10
29
371
3908
18
69
343
3685
nystatin
D01AA01 [21601911]
1.7e+00
—
—
—
—
—
1.6e+00
cases:2.27%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.64%
9
16
387
3951
—
—
—
—
—
11
24
350
3730
nystatin; vaginal
G01AA01 [21602363]
1.7e+00
—
—
—
—
—
1.6e+00
cases:2.27%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.64%
9
16
387
3951
—
—
—
—
—
11
24
350
3730
metronidazole and furazolidone
P01AB51 [45893518]
1.7e+00
—
—
—
—
—
1.6e+00
cases:2.27%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.64%
9
16
387
3951
—
—
—
—
—
11
24
350
3730
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
—
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.60%
controls:0.13%
—
—
—
—
—
—
13
5
348
3749
Bacteria identified in Isolate by Culture
43409-2 [3042936]
—
2.0e+00
—
—
—
—
1.3e+00
—
—
cases:1.51%
controls:0.20%
—
—
—
—
—
—
—
—
cases:4.43%
controls:1.31%
—
6
8
391
3966
—
—
—
—
16
49
345
3705
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
9.9e-01
1.5e+00
—
—
—
9.3e-01
7.9e-01
cases:6.06%
controls:2.34%
cases:3.27%
controls:0.75%
—
—
—
—
—
—
cases:2.10%
controls:0.84%
cases:9.70%
controls:4.66%
24
93
372
3874
13
30
384
3944
—
—
—
8
33
373
3904
35
175
326
3579
Removal of sutures
SPAT1153 [2001700254]
5.0e-01
1.3e+00
—
—
2.5e+00
1.5e+00
7.6e-01
cases:2.27%
controls:1.39%
cases:2.27%
controls:0.60%
—
—
—
—
cases:1.52%
controls:0.13%
cases:1.84%
controls:0.43%
cases:6.93%
controls:3.36%
9
55
387
3912
9
24
388
3950
—
—
6
5
388
3966
7
17
374
3920
25
126
336
3628
codeine and paracetamol
N02AJ06 [1123647]
5.7e-01
8.5e-01
1.8e+00
—
1.0e+00
7.1e-01
6.0e-01
cases:11.36%
controls:6.78%
cases:6.55%
controls:2.92%
cases:4.03%
controls:0.68%
—
—
cases:1.27%
controls:0.45%
cases:6.82%
controls:3.48%
cases:18.28%
controls:10.90%
45
269
351
3698
26
116
371
3858
16
27
381
3947
—
5
18
389
3953
26
137
355
3800
66
409
295
3345
amoxicillin; oral, parenteral
J01CA04 [21602823]
3.8e-01
8.7e-01
1.8e+00
—
1.2e+00
3.0e-01
5.9e-01
cases:27.02%
controls:20.27%
cases:13.85%
controls:6.29%
cases:2.77%
controls:0.48%
—
—
cases:1.78%
controls:0.55%
cases:8.66%
controls:6.55%
cases:32.13%
controls:20.72%
107
804
289
3163
55
250
342
3724
11
19
386
3955
—
7
22
387
3949
33
258
348
3679
116
778
245
2976
Oncology Clinic/Center
261QX0200X [38004268]
1.2e+00
2.0e+00
—
—
—
1.1e+00
2.8e-01
cases:9.60%
controls:3.13%
cases:6.80%
controls:0.93%
—
—
—
—
—
—
cases:3.15%
controls:1.04%
cases:6.09%
controls:4.69%
38
124
358
3843
27
37
370
3937
—
—
—
12
41
369
3896
22
176
339
3578
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.5e-01
1.2e-01
1.7e+00
—
1.6e+00
2.1e-01
1.1e-02
cases:5.30%
controls:6.13%
cases:6.30%
controls:5.64%
cases:5.04%
controls:1.01%
—
—
cases:5.33%
controls:1.16%
cases:7.87%
controls:6.50%
cases:19.94%
controls:19.77%
21
243
375
3724
25
224
372
3750
20
40
377
3934
—
21
46
373
3925
30
256
351
3681
72
742
289
3012
temazepam; oral
N05CD07 [21604642]
5.0e-01
1.1e+00
—
—
—
1.1e+00
1.1e+00
cases:4.29%
controls:2.65%
cases:4.03%
controls:1.41%
—
—
—
—
—
—
cases:4.20%
controls:1.50%
cases:7.20%
controls:2.56%
17
105
379
3862
16
56
381
3918
—
—
—
16
59
365
3878
26
96
335
3658
gabapentin; oral
N02BF01 [955005]
9.3e-01
1.7e+00
—
—
—
1.3e+00
1.5e+00
cases:2.53%
controls:1.01%
cases:2.27%
controls:0.40%
—
—
—
—
—
—
cases:1.84%
controls:0.48%
cases:6.37%
controls:1.55%
10
40
386
3927
9
16
388
3958
—
—
—
7
19
374
3918
23
58
338
3696
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
8.3e-01
1.2e+00
—
—
—
2.0e+00
1.2e+00
cases:1.77%
controls:0.78%
cases:1.76%
controls:0.55%
—
—
—
—
—
—
cases:3.15%
controls:0.43%
cases:8.03%
controls:2.61%
7
31
389
3936
7
22
390
3952
—
—
—
12
17
369
3920
29
98
332
3656
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.8e+00
—
—
—
—
—
1.4e+00
cases:2.02%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.75%
8
14
388
3953
—
—
—
—
—
11
28
350
3726
Dentistry
C5 [903277]
1.0e+00
2.1e+00
—
—
—
1.5e+00
6.1e-01
cases:4.04%
controls:1.49%
cases:3.53%
controls:0.45%
—
—
—
—
—
—
cases:2.36%
controls:0.56%
cases:3.05%
controls:1.68%
16
59
380
3908
14
18
383
3956
—
—
—
9
22
372
3915
11
63
350
3691
nystatin; oral
A07AA02 [21600604]
1.5e+00
—
—
—
—
—
1.6e+00
cases:2.53%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.72%
10
22
386
3945
—
—
—
—
—
12
27
349
3727
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
1.3e+00
2.0e+00
—
—
—
1.5e+00
1.0e+00
cases:1.77%
controls:0.50%
cases:3.02%
controls:0.40%
—
—
—
—
—
—
cases:2.10%
controls:0.46%
cases:6.09%
controls:2.24%
7
20
389
3947
12
16
385
3958
—
—
—
8
18
373
3919
22
84
339
3670
Erysipelas
A46 [45561706]
5.5e-01
—
—
—
—
2.0e+00
1.1e+00
cases:1.52%
controls:0.88%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.25%
cases:4.43%
controls:1.55%
6
35
390
3932
—
—
—
—
7
10
374
3927
16
58
345
3696
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.19%
—
—
—
—
—
—
14
7
347
3747
erdosteine; oral
R05CB15 [21603394]
9.8e-01
—
—
—
—
1.9e+00
1.1e+00
cases:1.26%
controls:0.48%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.28%
cases:5.82%
controls:1.97%
5
19
391
3948
—
—
—
—
7
11
374
3926
21
74
340
3680
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
5.0e-01
1.9e+00
—
—
—
1.7e+00
1.1e+00
cases:1.77%
controls:1.08%
cases:2.52%
controls:0.40%
—
—
—
—
—
—
cases:1.84%
controls:0.36%
cases:6.09%
controls:2.05%
7
43
389
3924
10
16
387
3958
—
—
—
7
14
374
3923
22
77
339
3677
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.13%
—
—
—
—
—
—
9
5
352
3749
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.13%
—
—
—
—
—
—
9
5
352
3749
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.13%
—
—
—
—
—
—
9
5
352
3749
zopiclone; oral
N05CF01 [21604654]
6.2e-01
8.3e-01
9.6e-01
—
7.4e-01
8.7e-01
5.9e-01
cases:12.12%
controls:6.91%
cases:9.32%
controls:4.28%
cases:2.52%
controls:0.98%
—
—
cases:2.28%
controls:1.11%
cases:9.97%
controls:4.42%
cases:14.13%
controls:8.36%
48
274
348
3693
37
170
360
3804
10
39
387
3935
—
9
44
385
3927
38
174
343
3763
51
314
310
3440
Atrial fibrillation and flutter
I48 [45596206]
4.4e-01
1.0e+00
1.7e+00
—
1.5e+00
9.6e-01
8.9e-01
cases:4.29%
controls:2.80%
cases:4.28%
controls:1.59%
cases:1.51%
controls:0.28%
—
—
cases:1.27%
controls:0.28%
cases:4.20%
controls:1.65%
cases:9.42%
controls:4.10%
17
111
379
3856
17
63
380
3911
6
11
391
3963
—
5
11
389
3960
16
65
365
3872
34
154
327
3600
candesartan; oral
C09CA06 [21601829]
9.2e-01
1.0e+00
1.3e+00
—
7.9e-01
9.2e-01
7.0e-01
cases:6.31%
controls:2.62%
cases:5.04%
controls:1.91%
cases:1.76%
controls:0.50%
—
—
cases:1.27%
controls:0.58%
cases:4.99%
controls:2.06%
cases:7.20%
controls:3.70%
25
104
371
3863
20
76
377
3898
7
20
390
3954
—
5
23
389
3948
19
81
362
3856
26
139
335
3615
Bronchial lavation
TGC00 [2001303585]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.13%
—
—
—
—
—
—
8
5
353
3749
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.1e+00
2.3e+00
—
—
1.0e+50
—
2.8e+00
cases:1.52%
controls:0.50%
cases:1.26%
controls:0.13%
—
—
—
—
cases:1.78%
controls:0.00%
—
—
cases:3.05%
controls:0.19%
6
20
390
3947
5
5
392
3969
—
—
7
0
387
3971
—
11
7
350
3747
Bilateral
ZXA10 [2001311348]
5.0e-01
1.8e+00
—
—
—
1.0e+00
9.9e-01
cases:2.27%
controls:1.39%
cases:2.77%
controls:0.45%
—
—
—
—
—
—
cases:1.31%
controls:0.48%
cases:4.71%
controls:1.81%
9
55
387
3912
11
18
386
3956
—
—
—
5
19
376
3918
17
68
344
3686
warfarin; oral, parenteral
B01AA03 [21600965]
6.4e-01
8.9e-01
3.9e-01
—
6.3e-01
9.2e-01
9.6e-01
cases:6.82%
controls:3.71%
cases:7.05%
controls:3.02%
cases:1.26%
controls:0.86%
—
—
cases:1.27%
controls:0.68%
cases:7.35%
controls:3.07%
cases:11.08%
controls:4.56%
27
147
369
3820
28
120
369
3854
5
34
392
3940
—
5
27
389
3944
28
121
353
3816
40
171
321
3583
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.2e+00
—
—
—
—
2.8e+00
9.7e-01
cases:1.26%
controls:0.38%
—
—
—
—
—
—
—
—
cases:2.36%
controls:0.15%
cases:3.05%
controls:1.17%
5
15
391
3952
—
—
—
—
9
6
372
3931
11
44
350
3710
Acute maxillary sinusitis
J01.0 [45601112]
1.3e+00
—
—
—
—
1.4e+00
7.9e-01
cases:5.05%
controls:1.39%
—
—
—
—
—
—
—
—
cases:2.89%
controls:0.71%
cases:6.09%
controls:2.85%
20
55
376
3912
—
—
—
—
11
28
370
3909
22
107
339
3647
Standard cardiac ultrasound examination
FM1AE [2001303278]
1.1e+00
1.7e+00
—
1.0e+50
—
1.1e+00
6.6e-01
cases:4.29%
controls:1.51%
cases:3.27%
controls:0.63%
—
—
cases:1.26%
controls:0.00%
—
—
cases:2.10%
controls:0.69%
cases:3.88%
controls:2.05%
17
60
379
3907
13
25
384
3949
—
5
0
392
3974
—
8
27
373
3910
14
77
347
3677
Inpatient Visit
IP [9201]
6.8e-01
1.7e+00
—
1.0e+50
—
—
1.1e+00
cases:4.80%
controls:2.50%
cases:2.02%
controls:0.38%
—
—
cases:1.76%
controls:0.00%
—
—
—
—
cases:5.54%
controls:2.00%
19
99
377
3868
8
15
389
3959
—
7
0
390
3974
—
—
20
75
341
3679
Heart failure, unspecified
I50.9 [45576879]
9.3e-01
8.3e-01
—
—
—
1.6e+00
1.2e+00
cases:2.02%
controls:0.81%
cases:1.26%
controls:0.55%
—
—
—
—
—
—
cases:2.62%
controls:0.56%
cases:4.71%
controls:1.52%
8
32
388
3935
5
22
392
3952
—
—
—
10
22
371
3915
17
57
344
3697
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.3e-01
6.2e-01
1.4e+00
—
1.3e+00
5.3e-01
2.8e-01
cases:7.58%
controls:6.10%
cases:9.57%
controls:5.41%
cases:4.03%
controls:1.03%
—
—
cases:4.06%
controls:1.11%
cases:11.29%
controls:6.93%
cases:26.32%
controls:21.23%
30
242
366
3725
38
215
359
3759
16
41
381
3933
—
16
44
378
3927
43
273
338
3664
95
797
266
2957
Other and unspecified intestinal obstruction
K56.6 [45562499]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.13%
—
—
—
—
—
—
7
5
354
3749
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
1.7e-01
6.1e-01
2.0e+00
—
1.4e+00
4.7e-01
7.3e-01
cases:3.03%
controls:2.57%
cases:3.02%
controls:1.66%
cases:1.76%
controls:0.25%
—
—
cases:1.27%
controls:0.33%
cases:2.89%
controls:1.83%
cases:14.40%
controls:7.49%
12
102
384
3865
12
66
385
3908
7
10
390
3964
—
5
13
389
3958
11
72
370
3865
52
281
309
3473
salmeterol and fluticasone
R03AK06 [21603280]
9.1e-01
9.6e-01
—
—
—
8.2e-01
8.2e-01
cases:5.05%
controls:2.09%
cases:4.28%
controls:1.69%
—
—
—
—
—
—
cases:3.94%
controls:1.78%
cases:6.65%
controls:3.04%
20
83
376
3884
17
67
380
3907
—
—
—
15
70
366
3867
24
114
337
3640
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.16%
—
—
—
—
—
—
8
6
353
3748
Other specified special examinations
Z01.8 [45581003]
8.5e-01
1.4e+00
—
—
—
1.4e+00
1.2e+00
cases:4.80%
controls:2.12%
cases:2.52%
controls:0.63%
—
—
—
—
—
—
cases:1.31%
controls:0.33%
cases:6.93%
controls:2.26%
19
84
377
3883
10
25
387
3949
—
—
—
5
13
376
3924
25
85
336
3669
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.4e+00
—
—
—
—
1.4e+00
1.1e+00
cases:2.53%
controls:0.60%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.46%
cases:4.16%
controls:1.41%
10
24
386
3943
—
—
—
—
7
18
374
3919
15
53
346
3701
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
Y57 [45756618]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.13%
—
—
—
—
—
—
6
5
355
3749
Hemodialysis
TK800 [2001305768]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.13%
0
6
396
3961
—
—
—
—
—
6
5
355
3749
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.13%
—
—
—
—
—
—
6
5
355
3749
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
—
—
—
—
—
2.5e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.13%
cases:1.66%
controls:0.24%
—
—
—
—
—
6
5
375
3932
6
9
355
3745
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.16%
—
—
—
—
—
—
7
6
354
3748
General Practice Dentistry
1223G0001X [38003675]
1.7e+00
—
—
—
—
—
2.5e+00
cases:1.26%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:4.71%
controls:0.40%
5
9
391
3958
—
—
—
—
—
17
15
344
3739
alendronic acid; oral
M05BA04 [21604152]
8.1e-01
1.3e+00
-1.0e+50
—
—
1.0e+00
1.2e+00
cases:2.78%
controls:1.26%
cases:2.77%
controls:0.75%
cases:0.00%
controls:0.20%
—
—
—
—
cases:2.89%
controls:1.04%
cases:5.26%
controls:1.68%
11
50
385
3917
11
30
386
3944
0
8
397
3966
—
—
11
41
370
3896
19
63
342
3691
oseltamivir; oral
J05AH02 [21603179]
2.5e+00
—
—
—
—
—
—
cases:1.52%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
390
3962
—
—
—
—
—
—
Other complications of procedures, not elsewhere classified
T81.8 [45599753]
2.5e+00
1.0e+50
1.0e+50
—
—
—
—
cases:1.52%
controls:0.13%
cases:2.02%
controls:0.00%
cases:2.02%
controls:0.00%
—
—
—
—
—
—
—
—
6
5
390
3962
8
0
389
3974
8
0
389
3974
—
—
—
—
Electrocardiogram with exercise test
46136006 [4261794]
—
2.5e+00
—
—
—
—
8.3e-01
—
—
cases:1.51%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.85%
—
6
5
391
3969
—
—
—
—
7
32
354
3722
bisoprolol; oral
C07AB07 [21601689]
2.1e-01
3.7e-01
5.6e-01
—
1.0e+00
8.0e-01
6.8e-01
cases:12.37%
controls:10.26%
cases:12.09%
controls:8.66%
cases:4.03%
controls:2.34%
—
—
cases:5.84%
controls:2.19%
cases:18.37%
controls:9.19%
cases:24.65%
controls:14.25%
49
407
347
3560
48
344
349
3630
16
93
381
3881
—
23
87
371
3884
70
362
311
3575
89
535
272
3219
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.21%
—
—
—
—
—
—
9
8
352
3746
Other seropositive rheumatoid arthritis
M05.8 [45538634]
1.1e+00
1.3e+00
—
—
—
1.1e+00
9.3e-01
cases:3.28%
controls:1.08%
cases:3.27%
controls:0.91%
—
—
—
—
—
—
cases:3.15%
controls:1.07%
cases:3.88%
controls:1.57%
13
43
383
3924
13
36
384
3938
—
—
—
12
42
369
3895
14
59
347
3695
Pneumonia, unspecified
J18.9 [45601123]
8.5e-01
1.3e+00
—
—
—
1.0e+00
1.2e+00
cases:3.54%
controls:1.54%
cases:3.78%
controls:1.08%
—
—
—
—
—
—
cases:2.89%
controls:1.07%
cases:9.42%
controls:3.17%
14
61
382
3906
15
43
382
3931
—
—
—
11
42
370
3895
34
119
327
3635
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.7e-01
8.3e-01
1.9e+00
—
1.4e+00
5.8e-01
5.6e-01
cases:3.79%
controls:2.92%
cases:4.79%
controls:2.14%
cases:2.52%
controls:0.40%
—
—
cases:1.27%
controls:0.33%
cases:4.72%
controls:2.69%
cases:15.79%
controls:9.64%
15
116
381
3851
19
85
378
3889
10
16
387
3958
—
5
13
389
3958
18
106
363
3831
57
362
304
3392
combinations of corticosteroids
D07XB30 [21602188]
5.6e-01
1.1e+00
—
—
—
8.0e-01
5.2e-01
cases:16.41%
controls:10.06%
cases:7.56%
controls:2.77%
—
—
—
—
—
—
cases:6.56%
controls:3.07%
cases:15.24%
controls:9.70%
65
399
331
3568
30
110
367
3864
—
—
—
25
121
356
3816
55
364
306
3390
combinations of corticosteroids
D07AB30 [21602118]
5.6e-01
1.1e+00
—
—
—
8.0e-01
5.2e-01
cases:16.41%
controls:10.06%
cases:7.56%
controls:2.77%
—
—
—
—
—
—
cases:6.56%
controls:3.07%
cases:15.24%
controls:9.70%
65
399
331
3568
30
110
367
3864
—
—
—
25
121
356
3816
55
364
306
3390
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.29%
—
—
—
—
—
—
11
11
350
3743
Dietary counselling and surveillance
Z71.3 [45552101]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.19%
—
—
—
—
—
—
7
7
354
3747
Post-traumatic stress disorder
F43.1 [45595909]
—
-1.0e+50
—
—
—
-1.0e+50
2.4e+00
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.39%
controls:0.13%
—
0
6
397
3968
—
—
—
0
5
381
3932
5
5
356
3749
Nausea
D09 [2002000308]
—
—
—
—
—
-1.0e+50
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.39%
controls:0.13%
—
—
—
—
—
0
5
381
3932
5
5
356
3749
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
—
—
—
—
—
2.3e+00
8.1e-01
—
—
—
—
—
—
—
—
—
—
cases:1.57%
controls:0.15%
cases:5.54%
controls:2.53%
—
—
—
—
—
6
6
375
3931
20
95
341
3659
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
—
—
—
—
—
2.3e+00
8.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.13%
cases:1.66%
controls:0.72%
—
—
—
—
—
5
5
376
3932
6
27
355
3727
Kolposcopy
ULA02 [2001306679]
1.3e+00
2.3e+00
—
—
—
—
—
cases:2.02%
controls:0.58%
cases:2.02%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
8
23
388
3944
8
8
389
3966
—
—
—
—
—
Angiography of the heart and coronary arteries
81 [2002100125]
8.1e-01
2.3e+00
—
—
—
—
—
cases:2.02%
controls:0.91%
cases:1.76%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
8
36
388
3931
7
7
390
3967
—
—
—
—
—
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
—
2.3e+00
—
—
—
—
7.1e-01
—
—
cases:1.51%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.83%
—
6
6
391
3968
—
—
—
—
6
31
355
3723
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
—
2.3e+00
—
—
—
2.2e+00
1.1e+00
—
—
cases:1.51%
controls:0.15%
—
—
—
—
—
—
cases:1.31%
controls:0.15%
cases:2.77%
controls:0.93%
—
6
6
391
3968
—
—
—
5
6
376
3931
10
35
351
3719
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.8e-01
1.3e+00
—
—
—
7.9e-01
9.9e-01
cases:2.02%
controls:1.26%
cases:2.77%
controls:0.75%
—
—
—
—
—
—
cases:2.10%
controls:0.97%
cases:9.42%
controls:3.70%
8
50
388
3917
11
30
386
3944
—
—
—
8
38
373
3899
34
139
327
3615
Neck ultrasound examination
EP1AE [2001302284]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.77%
controls:0.29%
—
—
—
—
—
—
10
11
351
3743
High resolution CT examination of lungs
GD1DD [2001303632]
1.4e+00
—
—
—
—
—
2.3e+00
cases:1.26%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.27%
5
12
391
3955
—
—
—
—
—
9
10
352
3744
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.24%
—
—
—
—
—
—
8
9
353
3745
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.24%
—
—
—
—
—
—
8
9
353
3745
Ultrasound examination of mammary glands
HA1AE [2001303886]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.60%
controls:0.40%
—
—
—
—
—
—
13
15
348
3739
budesonide; oral, sublingual
A07EA06 [21600658]
1.8e+00
—
—
—
—
—
2.2e+00
cases:1.26%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.21%
5
8
391
3959
—
—
—
—
—
7
8
354
3746
Aortic (valve) stenosis
I35.0 [45576869]
—
—
—
—
—
2.2e+00
9.7e-01
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.20%
cases:2.22%
controls:0.85%
—
—
—
—
—
7
8
374
3929
8
32
353
3722
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.37%
0
5
396
3962
—
—
—
—
—
12
14
349
3740
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
—
2.2e+00
—
—
—
—
5.8e-01
—
—
cases:2.02%
controls:0.23%
—
—
—
—
—
—
—
—
cases:2.22%
controls:1.25%
—
8
9
389
3965
—
—
—
—
8
47
353
3707
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
6.8e-01
2.2e+00
—
—
—
1.7e+00
1.1e+00
cases:1.77%
controls:0.91%
cases:2.02%
controls:0.23%
—
—
—
—
—
—
cases:1.57%
controls:0.30%
cases:3.05%
controls:1.07%
7
36
389
3931
8
9
389
3965
—
—
—
6
12
375
3925
11
40
350
3714
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.19%
—
—
—
—
—
—
6
7
355
3747
ursodeoxycholic acid; oral
A05AA02 [21600513]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.19%
—
—
—
—
—
—
6
7
355
3747
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.19%
—
—
—
—
—
—
6
7
355
3747
Leiomyoma of uterus, unspecified
D25.9 [45542693]
—
2.2e+00
1.0e+50
—
—
-1.0e+50
—
—
—
cases:1.76%
controls:0.20%
cases:2.02%
controls:0.00%
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
7
8
390
3966
8
0
389
3974
—
—
0
8
381
3929
—
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.8e-01
1.2e+00
—
—
—
8.2e-01
1.0e+00
cases:4.04%
controls:1.89%
cases:4.03%
controls:1.28%
—
—
—
—
—
—
cases:2.10%
controls:0.94%
cases:11.08%
controls:4.40%
16
75
380
3892
16
51
381
3923
—
—
—
8
37
373
3900
40
165
321
3589
Fall into hole or other opening in surface
E883A [2000408881]
2.2e+00
—
—
—
—
—
—
cases:1.52%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
390
3960
—
—
—
—
—
—
Special examination of mouth
SAA04 [2001310277]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.29%
—
—
—
—
—
—
9
11
352
3743
Thorax CT examination
GD1AD [2001303618]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.29%
—
—
—
—
—
—
9
11
352
3743
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.49%
controls:0.29%
—
—
—
—
—
—
9
11
352
3743
Telehealth
OMOP5556618 [722455]
2.4e-01
3.9e-01
1.4e+00
—
4.8e-01
7.4e-01
4.1e-01
cases:10.86%
controls:8.72%
cases:8.56%
controls:5.96%
cases:3.53%
controls:0.88%
—
—
cases:1.78%
controls:1.11%
cases:12.86%
controls:6.60%
cases:26.32%
controls:19.13%
43
346
353
3621
34
237
363
3737
14
35
383
3939
—
7
44
387
3927
49
260
332
3677
95
718
266
3036
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.27%
—
—
—
—
—
—
8
10
353
3744
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.37%
—
—
—
—
—
—
11
14
350
3740
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.24%
—
—
—
—
—
—
7
9
354
3745
Bone marrow biopsy
XW000 [2001310618]
1.6e+00
—
—
—
—
—
2.1e+00
cases:1.26%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.24%
5
10
391
3957
—
—
—
—
—
7
9
354
3745
Immunohistochemistry procedure
117617002 [4035726]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.77%
controls:0.35%
—
—
—
—
—
—
10
13
351
3741
tamoxifen; oral
L02BA01 [21603831]
—
—
—
—
—
2.1e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:2.22%
controls:0.51%
—
—
—
—
—
7
9
374
3928
8
19
353
3735
ranitidine bismuth citrate; oral
A02BA07 [21600088]
8.2e-01
6.8e-01
-1.0e+50
—
-1.0e+50
1.1e+00
1.3e+00
cases:6.82%
controls:3.13%
cases:2.02%
controls:1.03%
cases:0.00%
controls:0.15%
—
—
cases:0.00%
controls:0.15%
cases:2.36%
controls:0.81%
cases:6.09%
controls:1.78%
27
124
369
3843
8
41
389
3933
0
6
397
3968
—
0
6
394
3965
9
32
372
3905
22
67
339
3687
ranitidine; oral, parenteral
A02BA02 [21600083]
8.2e-01
6.8e-01
-1.0e+50
—
-1.0e+50
1.1e+00
1.3e+00
cases:6.82%
controls:3.13%
cases:2.02%
controls:1.03%
cases:0.00%
controls:0.15%
—
—
cases:0.00%
controls:0.15%
cases:2.36%
controls:0.81%
cases:6.09%
controls:1.78%
27
124
369
3843
8
41
389
3933
0
6
397
3968
—
0
6
394
3965
9
32
372
3905
22
67
339
3687
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.32%
controls:0.43%
—
—
—
—
—
—
12
16
349
3738
Other specified local infections of skin and subcutaneous tissue
L08.8 [45601211]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.21%
—
—
—
—
—
—
6
8
355
3746
Other chronic renal failure
N18.8 [45534123]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.21%
—
—
—
—
—
—
6
8
355
3746
Blasts/Leukocytes in Blood
26446-5 [3025159]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.05%
controls:0.40%
—
—
—
—
—
—
11
15
350
3739
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.29%
—
—
—
—
—
—
8
11
353
3743
Rehabilitation Hospital
283X00000X [38004285]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.29%
—
—
—
—
—
—
8
11
353
3743
Extensive abdominal CT
JN3BD [2001305556]
1.3e+00
—
—
1.0e+50
—
—
2.0e+00
cases:1.77%
controls:0.48%
—
—
—
—
cases:1.51%
controls:0.00%
—
—
—
—
cases:4.71%
controls:0.64%
7
19
389
3948
—
—
6
0
391
3974
—
—
17
24
344
3730
Iron deficiency anaemia, unspecified
D50.9 [45605373]
2.0e+00
—
—
—
—
—
8.8e-01
cases:2.27%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.69%
9
12
387
3955
—
—
—
—
—
6
26
355
3728
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
2.0e+00
—
—
—
—
—
1.3e+00
cases:1.52%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.48%
6
8
390
3959
—
—
—
—
—
6
18
355
3736
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
—
—
1.0e+50
—
—
—
2.0e+00
—
—
—
—
cases:1.51%
controls:0.00%
—
—
—
—
—
—
cases:2.77%
controls:0.37%
—
—
6
0
391
3974
—
—
—
10
14
351
3740
X-ray examination of the lungs in one projection
GD1PA [2001303645]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.53%
—
—
—
—
—
—
14
20
347
3734
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
3.4e-01
2.0e+00
—
—
—
—
4.0e-02
cases:2.78%
controls:1.99%
cases:2.77%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.39%
controls:1.33%
11
79
385
3888
11
15
386
3959
—
—
—
—
5
50
356
3704
ispaghula (psylla seeds); oral
A06AC01 [21600555]
3.2e-01
9.8e-01
—
—
—
1.2e+00
8.5e-01
cases:2.78%
controls:2.04%
cases:2.77%
controls:1.06%
—
—
—
—
—
—
cases:3.41%
controls:1.09%
cases:7.76%
controls:3.46%
11
81
385
3886
11
42
386
3932
—
—
—
13
43
368
3894
28
130
333
3624
Nursing episode
950 [44777714]
—
—
—
—
—
2.0e+00
5.9e-01
—
—
—
—
—
—
—
—
—
—
cases:3.15%
controls:0.43%
cases:3.05%
controls:1.70%
—
—
—
—
—
12
17
369
3920
11
64
350
3690
hydrocortisone; oral, parenteral
H02AB09 [21602737]
7.3e-01
2.0e+00
—
—
—
—
9.5e-01
cases:2.53%
controls:1.24%
cases:2.02%
controls:0.28%
—
—
—
—
—
—
—
—
cases:3.05%
controls:1.20%
10
49
386
3918
8
11
389
3963
—
—
—
—
11
45
350
3709
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.27%
—
0
5
397
3969
—
—
—
—
7
10
354
3744

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
29
29
10.70
25.90
3.9
1.9
1249.59
1338.00
e6/l
0.11
22
23
165
904
2.40
15.72
3.6
2.3
2.90
2.93
mg/l
0.06
148
785
91
382
2.79
15.05
2.7
1.7
—
—
—
0
0
25
24
11.03
13.43
3.8
2.0
566.29
583.18
e6/l
0.03
17
17
24
22
11.53
13.20
4.1
2.1
184.06
208.76
e6/l
0.21
18
17
18
8
23.47
13.00
6.3
1.3
633.33
790.88
u/ml
—
18
8
61
229
2.96
12.27
4.5
1.6
1.23
1.65
g/l
0.63
54
210
109
547
2.36
12.20
3.0
2.4
2.36
2.30
g/l
0.51
99
506
115
593
2.32
12.07
3.2
2.4
12.10
12.93
umol/l
0.56
104
551
158
930
2.15
11.96
7.6
4.3
—
—
—
0
0
25
51
5.16
11.84
1.6
1.3
0.28
0.66
g/l
2.20
17
44
99
494
2.33
11.12
3.0
2.1
—
—
—
0
0
23
29
8.34
10.74
1.4
1.2
4.93
6.57
g/l
2.26
13
24
23
29
8.34
10.74
1.4
1.2
1.74
2.86
g/l
1.91
14
23
23
29
8.34
10.74
1.4
1.2
0.33
0.34
g/l
0.08
14
23
101
518
2.27
10.59
3.5
2.4
21.92
22.51
%
0.14
92
488
223
1539
2.01
10.57
8.6
4.7
34.52
35.61
g/l
2.08
214
1451
84
406
2.35
10.07
4.0
2.9
1.87
1.80
%
0.25
77
367
22
30
7.69
9.83
1.4
1.2
—
—
—
0
0
222
1585
1.90
8.96
14.0
6.7
1.21
1.22
mmol/l
0.22
207
1468
26
71
3.85
8.59
3.2
1.2
11.08
10.88
mg/l
0.05
26
64
245
1823
1.88
8.52
9.9
6.1
10.46
12.35
umol/l
2.24
236
1747
211
1500
1.86
8.46
2.5
2.1
96.56
96.08
pmol/l
0.05
122
770
116
685
1.98
8.18
4.7
3.6
177.13
377.61
ng/l
0.69
87
535
235
1747
1.83
7.97
15.1
7.1
1.21
1.22
mmol/l
0.22
204
1509
63
303
2.28
7.54
4.5
2.6
71.82
70.01
e9/l
0.11
43
225
234
1762
1.79
7.36
13.9
5.9
0.62
0.57
e9/l
1.96
206
1499
239
1812
1.79
7.33
14.1
6.4
0.20
0.19
e9/l
0.32
214
1573
234
1766
1.78
7.27
13.9
5.9
0.04
0.04
e9/l
0.09
206
1503
86
477
2.02
7.14
10.4
5.0
1.04
1.06
mmol/l
0.26
79
436
84
465
2.02
7.01
15.7
7.5
103.90
104.58
mmol/l
0.56
84
465
253
1968
1.77
6.94
18.3
9.5
4.57
4.08
e9/l
2.21
227
1707
221
1656
1.75
6.89
14.3
6.0
26.99
27.92
%
0.56
215
1573
235
1794
1.75
6.84
14.0
5.9
2.00
1.98
e9/l
0.06
212
1576
216
1614
1.73
6.76
14.7
6.0
0.60
0.68
%
1.49
209
1507
75
404
2.05
6.73
4.3
2.8
5.05
7.70
umol/l
2.40
66
353
56
269
2.26
6.71
4.8
3.4
94.00
81.56
ng/l
0.51
50
238
219
1649
1.72
6.61
4.7
3.0
152.63
112.82
ug/l
1.43
204
1537
156
1071
1.75
6.56
4.0
2.4
58.78
60.82
u/l
0.11
149
998
215
1622
1.70
6.35
14.7
6.0
8.89
8.77
%
0.20
209
1526
214
1615
1.70
6.29
14.7
6.0
2.84
2.84
%
0.01
208
1514
156
1081
1.73
6.28
7.4
3.9
7.39
7.40
ph
0.61
121
762
96
576
1.88
6.28
6.7
3.3
0.80
0.82
mmol/l
0.89
89
549
71
385
2.03
6.23
11.0
9.2
1.67
0.77
mmol/l
1.20
63
321
163
1146
1.71
6.21
14.8
5.8
—
—
—
0
0
71
387
2.01
6.14
11.1
9.2
7.43
7.42
ph
0.73
42
221
51
246
2.23
6.04
8.7
3.6
7.41
7.42
ph
0.23
44
205
17
45
3.90
5.87
2.2
1.4
—
—
—
0
0
17
45
3.90
5.87
2.2
1.4
—
—
—
0
0
17
45
3.90
5.87
2.2
1.4
—
—
—
0
0
17
45
3.90
5.87
2.2
1.4
—
—
—
0
0
29
113
2.69
5.43
1.2
1.3
—
—
—
0
0
95
594
1.79
5.37
1.9
1.7
1228.20
1218.49
nmol/l
0.03
69
446
28
109
2.69
5.25
1.8
1.3
294.00
305.12
ug/g
0.11
20
69
69
393
1.91
5.23
11.3
9.1
11.98
12.08
kpa
0.05
64
379
69
393
1.91
5.23
11.3
9.1
5.31
5.08
kpa
1.32
64
376
71
410
1.89
5.17
1.9
1.4
—
—
—
0
0
15
41
3.76
4.97
3.1
1.7
22.13
29.26
ng/l
0.32
15
41
29
119
2.55
4.92
2.3
1.9
168.80
310.00
ug/l
1.04
29
112
34
151
2.37
4.88
2.0
2.0
1.64
1.47
g/l
0.41
28
137
40
191
2.22
4.87
1.3
1.3
—
—
—
0
0
302
2581
1.69
4.84
16.1
7.7
84.68
80.58
u/l
0.84
292
2438
46
233
2.10
4.83
1.8
1.2
449.72
375.89
u/ml
0.10
41
213
205
1598
1.58
4.82
25.6
12.9
1.30
1.25
inr
0.67
177
1322
9
10
9.17
4.80
2.3
3.0
0.60
0.61
mmol/l
—
9
10
136
963
1.62
4.79
4.5
3.2
—
0.00
estimate
—
0
5
79
486
1.78
4.68
1.7
1.4
420.00
543.79
titre
0.40
20
116
35
161
2.29
4.65
1.7
1.6
4.29
4.39
iu/ml
—
9
36
59
334
1.90
4.55
15.0
4.4
1.83
1.86
mmol/l
0.02
47
286
116
799
1.64
4.52
3.9
2.8
5.07
5.65
e6/l
0.34
109
737
61
351
1.87
4.47
14.6
4.4
7.37
7.38
ph
0.54
37
203
20
71
2.91
4.45
1.6
3.2
30.60
34.62
umol/l
0.39
15
66
139
1004
1.59
4.45
4.5
3.3
0.37
0.50
e6/l
0.34
112
738
57
324
1.89
4.34
3.3
2.4
37.44
28.81
u/l
0.66
52
266
109
748
1.63
4.29
3.2
1.4
2.11
2.47
g/l
1.09
66
451
19
67
2.93
4.28
4.8
2.8
—
—
—
0
0
45
237
2.01
4.27
3.5
2.8
163.62
203.19
ng/l
0.39
40
218
46
245
1.99
4.23
3.1
2.5
—
—
—
0
0
15
46
3.35
4.23
5.0
2.4
4.85
5.03
e9/l
0.08
15
46
25
103
2.52
4.22
4.8
3.3
1.19
1.67
index
0.35
16
57
54
306
1.88
4.15
22.4
9.1
—
—
—
0
0
40
204
2.07
4.14
8.0
6.8
—
—
—
0
0
22
87
2.62
4.04
1.5
2.0
119.53
124.92
g/l
0.34
15
64
175
1354
1.52
4.03
2.5
2.2
—
—
—
0
0
7
7
10.15
4.02
2.9
1.6
33.29
21.43
%
—
7
7
49
273
1.91
3.97
3.2
2.3
3.20
6.44
ug/l
2.38
40
243
156
1181
1.53
3.96
4.0
3.2
7.17
7.53
mmol/l
0.46
130
1003
109
765
1.58
3.87
2.6
1.8
1.39
1.49
mg/l
0.11
86
610
138
1023
1.53
3.84
1.9
1.7
18.69
21.27
nmol/l
1.34
120
855
193
1536
1.49
3.82
4.1
2.5
79.53
77.68
nmol/l
0.37
173
1389
15
50
3.08
3.73
3.5
2.6
—
—
—
0
0
75
485
1.67
3.69
2.0
1.6
—
—
—
0
0
102
713
1.58
3.66
4.3
3.0
518.71
529.79
mosm/kgh2o
0.22
94
632
12
30
4.09
3.62
4.0
2.6
—
—
—
0
0
152
1162
1.50
3.62
4.9
3.5
22.02
111.33
e6/l
0.93
124
887
142
1073
1.50
3.56
2.5
2.1
178.13
191.05
u/l
0.09
133
1024
61
377
1.73
3.53
2.0
1.6
—
—
—
0
0
141
1066
1.50
3.52
12.0
6.5
—
—
—
0
0
191
1534
1.47
3.52
20.9
11.4
0.00
0.00
e9/l
0.36
156
1247
151
1160
1.48
3.48
4.9
3.0
36.59
30.84
u/l
0.95
144
1106
242
2042
1.47
3.41
10.8
5.2
7.06
6.59
mmol/l
1.22
235
1935
57
350
1.73
3.38
4.4
2.0
340.38
391.89
nmol/l
1.24
52
324
11
28
4.01
3.31
1.4
1.1
—
—
—
0
0
41
231
1.86
3.23
1.1
1.2
—
—
—
0
0
68
444
1.64
3.21
2.4
2.3
171.36
131.43
ug/g
0.43
58
363
167
1329
1.44
3.13
5.8
4.2
156.01
125.75
e6/l
0.10
130
931
145
1124
1.45
3.13
3.6
2.3
—
—
—
0
0
70
464
1.62
3.12
1.5
1.2
—
—
—
0
0
81
560
1.56
3.02
3.6
3.2
2.84
2.70
e6/l
0.06
39
273
33
177
1.94
3.01
11.4
3.8
—
—
—
0
0
9
22
4.16
2.90
3.7
3.1
0.56
0.86
index
—
9
22
16
65
2.52
2.82
1.4
1.3
323.20
198.09
u/ml
—
10
33
139
1088
1.42
2.79
4.0
3.2
1813.18
1338.20
ng/l
0.67
124
930
10
29
3.51
2.71
1.3
1.1
—
—
—
0
0
17
73
2.39
2.69
2.4
1.9
—
—
—
0
0
9
24
3.81
2.68
2.3
3.2
542.67
849.38
mg
—
9
24
190
1584
1.38
2.59
4.4
2.7
—
—
estimate
—
0
0
78
553
1.51
2.59
1.8
1.9
—
—
—
0
0
110
839
1.43
2.51
1.4
1.3
0.98
1.48
u/ml
0.55
28
240
43
266
1.69
2.51
4.7
3.8
1.25
1.23
mmol/l
0.85
37
237
47
298
1.65
2.50
8.0
4.2
1.00
0.85
%
0.21
22
97
111
849
1.43
2.50
5.0
2.6
341.86
342.14
umol/l
0.01
99
744
15
63
2.43
2.49
1.1
1.1
—
—
—
0
0
178
1476
1.37
2.48
4.3
3.5
6.33
6.21
ph
0.67
110
837
10
32
3.18
2.45
1.9
1.5
—
—
—
0
0
39
237
1.72
2.43
2.9
2.6
11.54
12.76
nmol/l
0.39
33
215
6
12
5.06
2.41
2.7
1.3
—
—
—
0
0
15
65
2.36
2.34
1.7
1.4
114.60
151.80
au/ml
—
5
23
23
120
1.97
2.30
7.0
4.2
1866.79
330.06
mg/l
0.48
14
50
44
281
1.64
2.29
7.8
4.2
0.45
0.47
%
0.04
20
83
102
1299
0.71
2.29
3.5
3.2
—
—
—
0
0
7
18
3.94
2.26
1.3
1.1
—
—
—
0
0
44
282
1.63
2.26
8.2
4.4
0.11
0.10
%
0.02
19
80
20
100
2.05
2.25
4.7
4.3
1.51
2.94
ratio
1.12
12
55
39
243
1.67
2.23
1.6
1.5
—
—
—
0
0
46
303
1.59
2.12
1.7
1.4
—
—
—
0
0
29
169
1.77
2.10
2.4
2.3
—
—
—
0
0
59
413
1.50
2.08
1.3
1.4
—
—
—
0
0
9
31
2.95
2.08
1.8
1.9
—
—
—
0
0
8
26
3.12
2.02
1.5
1.2
90.88
107.62
pmol/l
—
8
26
13
57
2.32
1.99
1.1
1.1
—
—
—
0
0
10
39
2.60
1.95
1.1
1.0
—
—
—
0
0
11
45
2.49
1.94
1.5
1.1
1.47
1.40
g/l
0.37
11
39
136
1115
1.33
1.94
4.1
3.2
237.05
50.96
mg/l
0.70
92
709
9
34
2.68
1.87
1.6
1.2
—
—
—
0
0
20
110
1.86
1.76
5.9
4.8
42.42
52.48
mg/l
0.29
14
93
20
110
1.86
1.76
6.0
4.8
25.16
43.82
mg/l
0.51
13
92
12
54
2.26
1.75
1.0
1.3
—
—
—
0
0
43
293
1.52
1.74
8.9
4.6
0.00
0.16
%
0.74
17
74
147
1235
1.30
1.73
4.7
3.3
2.37
2.36
mmol/l
0.88
136
1121
8
180
0.43
1.73
2.8
1.7
—
—
—
0
0
15
75
2.04
1.72
6.3
2.3
63.13
59.34
%
0.52
15
75
19
104
1.87
1.70
1.4
1.2
—
—
—
0
0
91
716
1.35
1.69
1.8
1.7
432.03
6547091.03
pmol/l
0.50
74
611
6
20
3.03
1.58
1.0
3.5
107.17
160.15
nmol/l
—
6
20
135
1134
1.29
1.57
4.8
3.8
20.83
8.97
mg/mmol
1.24
87
696
302
3210
0.76
1.53
5.4
5.1
1.42
1.49
mmol/l
2.49
276
2973
5
15
3.36
1.53
1.4
1.1
—
—
—
0
0
5
15
3.36
1.53
4.0
2.7
—
—
—
0
0
60
452
1.39
1.47
1.5
1.3
—
—
—
0
0
24
149
1.65
1.44
1.4
1.2
—
—
—
0
0
257
2348
1.26
1.44
7.7
4.5
—
3.09
—
0
6
287
3063
0.78
1.43
4.4
4.3
1.43
1.26
mmol/l
3.23
260
2814
92
745
1.30
1.40
9.6
4.7
—
—
—
0
0
11
53
2.11
1.39
1.6
1.5
—
—
—
0
0
21
127
1.69
1.39
1.2
1.1
—
—
—
0
0
128
1089
1.26
1.32
3.9
3.1
—
—
—
0
0
57
434
1.37
1.32
5.3
3.0
5.12
5.57
e9/l
0.18
51
383
311
3274
0.78
1.28
6.1
5.9
2.53
2.71
mmol/l
3.22
285
3035
9
44
2.07
1.27
1.1
1.3
—
—
—
0
0
9
44
2.07
1.27
2.1
1.9
30.89
32.30
pg
—
9
44
153
1334
1.24
1.26
5.8
3.8
28.13
41.23
ng/l
1.30
112
952
8
36
2.25
1.25
1.1
1.1
—
—
—
0
0
45
334
1.39
1.22
2.6
2.2
0.00
0.04
estimate
0.49
11
69
17
101
1.71
1.21
1.8
1.6
328.00
296.49
mu/l
0.26
17
93
17
102
1.70
1.18
1.3
1.2
—
—
—
0
0
78
946
0.78
1.15
1.5
1.4
—
—
—
0
0
206
1865
1.22
1.15
5.4
3.9
0.00
4.19
estimate
0.50
47
388
17
103
1.68
1.14
1.5
1.3
—
—
—
0
0
7
30
2.36
1.13
3.9
3.1
—
—
—
0
0
40
296
1.39
1.11
7.2
3.6
7.39
7.32
ph
0.65
33
201
207
1882
1.21
1.09
5.4
4.0
0.00
0.02
estimate
0.80
44
362
7
33
2.14
1.06
1.3
1.1
—
—
—
0
0
39
293
1.37
1.01
1.2
1.2
—
—
—
0
0
15
92
1.65
0.98
2.2
1.9
2.28
5.23
iu/l
—
6
37
0
32
0.00
0.95
0.0
1.0
—
300.05
—
0
20
9
51
1.78
0.95
2.0
1.6
—
—
—
0
0
7
37
1.91
0.94
1.3
1.1
—
—
—
0
0
5
102
0.48
0.90
1.0
1.2
1.57
1.57
g/l
—
5
102
309
3223
0.82
0.89
5.3
5.2
4.42
4.67
mmol/l
4.38
289
3004
10
56
1.81
0.88
1.8
1.3
0.16
0.37
nmol/l
—
10
42
6
31
1.95
0.84
3.0
1.0
—
—
—
0
0
5
98
0.50
0.79
1.0
1.1
—
0.65
—
0
17
5
24
2.10
0.74
1.0
1.3
—
—
—
0
0
5
25
2.01
0.73
5.2
2.6
—
—
—
0
0
44
538
0.80
0.71
2.9
3.2
1.23
0.75
ug/l
0.32
31
338
7
40
1.76
0.71
4.1
6.1
9.43
11.26
%
—
7
40
15
101
1.50
0.71
1.6
1.4
—
—
—
0
0
199
1850
1.15
0.70
5.5
3.9
0.00
0.00
estimate
-0.00
44
376
277
2638
1.16
0.69
5.5
4.3
14.72
14.75
pmol/l
0.06
260
2414
24
179
1.36
0.68
3.0
2.2
0.00
0.02
estimate
—
7
58
348
3568
0.81
0.67
47.6
24.1
254.86
251.25
e9/l
0.42
343
3507
19
259
0.72
0.67
1.9
1.8
3.45
3.47
mmol/l
0.04
14
195
77
669
1.19
0.65
1.4
1.3
45.09
34.23
iu/ml
0.21
35
202
153
1405
1.14
0.63
2.1
2.0
1.49
1.36
mmol/l
1.17
119
1187
236
2233
1.14
0.61
4.8
3.2
61.24
46.17
u/l
2.21
221
2116
15
105
1.45
0.61
1.6
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
7.34
—
0
15
34
273
1.27
0.60
7.4
3.7
—
—
—
0
0
7
115
0.60
0.58
12.7
10.8
—
—
—
0
0
18
132
1.38
0.58
1.7
1.4
0.30
0.28
mg/l
—
9
54
8
54
1.49
0.57
1.5
1.9
—
—
—
0
0
6
36
1.68
0.57
1.8
1.3
—
—
—
0
0
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
15
107
1.42
0.56
1.6
1.4
—
—
—
0
0
15
107
1.42
0.56
1.6
1.4
—
—
—
0
0
338
3463
0.85
0.55
22.1
11.6
26.82
25.07
u/l
1.37
332
3370
6
38
1.59
0.54
1.8
3.6
4.07
3.12
nmol/l
—
6
38
6
38
1.59
0.54
1.5
1.0
—
—
—
0
0
6
39
1.55
0.53
2.0
2.2
—
—
—
0
0
308
3174
0.87
0.52
6.0
5.1
6.06
5.92
mmol/l
1.15
287
2925
299
3087
0.88
0.52
7.5
6.4
40.59
39.16
mmol/mol
1.82
287
2899
9
65
1.39
0.51
1.6
1.4
—
—
—
0
0
81
903
0.87
0.50
5.9
5.5
4.74
3.09
ug/l
0.42
70
807
18
136
1.34
0.50
2.1
2.8
—
—
—
0
0
7
106
0.65
0.49
1.1
1.2
0.88
0.89
g/l
—
7
106
7
45
1.57
0.49
1.3
1.3
—
—
nmol/l
—
0
0
7
47
1.50
0.48
1.3
1.1
—
—
—
0
0
7
47
1.50
0.48
3.1
2.9
3.50
85.98
u/ml
—
7
47
69
613
1.15
0.46
1.4
1.3
21.02
12.80
u/ml
0.27
23
234
91
827
1.13
0.44
5.4
4.1
1.02
1.02
kg/l
0.71
76
550
5
32
1.57
0.42
2.0
2.3
—
—
—
0
0
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
5
34
1.48
0.40
1.4
1.1
—
—
—
0
0
336
3287
1.14
0.40
35.4
15.9
26.81
23.82
mg/l
0.92
304
2703
0
19
0.00
0.39
0.0
1.2
—
74.53
—
0
19
10
72
1.40
0.37
2.0
2.9
7.75
9.07
pmol/l
—
10
72
42
367
1.16
0.36
4.9
4.0
3.61
38.03
ug/l
0.98
32
311
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
18
145
1.25
0.34
2.4
2.0
—
—
—
0
0
332
3380
0.90
0.32
28.2
14.0
—
—
—
0
0
14
173
0.80
0.29
1.1
1.1
—
—
—
0
0
5
74
0.67
0.26
2.2
2.4
59.40
46.00
ug/min
—
5
41
6
81
0.74
0.24
2.2
4.0
—
—
—
0
0
13
106
1.23
0.23
1.6
1.4
—
—
—
0
0
5
38
1.32
0.23
6.6
2.3
56.60
55.39
%
—
5
33
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
8.37
—
0
10
0
12
0.00
0.21
0.0
1.3
—
0.00
—
0
12
0
13
0.00
0.21
0.0
1.0
—
12.38
—
0
5
6
48
1.25
0.20
1.7
1.2
—
—
—
0
0
6
49
1.23
0.20
1.3
1.5
—
—
—
0
0
37
340
1.10
0.17
1.5
1.5
—
—
—
0
0
311
3071
1.06
0.15
7.1
5.4
2.05
1.90
mu/l
0.38
290
2824
7
64
1.10
0.08
1.0
1.1
—
—
—
0
0
7
64
1.10
0.08
1.0
1.1
—
—
—
0
0
24
254
0.94
0.06
2.0
1.8
—
—
—
0
0
76
741
1.03
0.06
3.9
2.7
2.49
2.45
mmol/l
1.43
65
669
26
248
1.05
0.05
1.6
1.2
50.37
167.36
u/ml
4.09
11
100
107
1053
1.02
0.05
6.8
4.1
0.00
0.01
estimate
0.50
44
349
142
1403
1.02
0.04
5.7
3.8
0.00
0.02
estimate
1.15
38
318
30
290
1.04
0.03
2.3
2.4
5.89
6.13
ph
0.74
19
188
33
339
0.97
0.02
2.6
1.5
—
—
—
0
0
102
1015
1.01
0.00
5.1
3.3
0.00
0.00
estimate
0.50
37
302
6
60
1.00
0.00
1.3
1.2
723.92
19.57
u/l
—
6
54
0
7
0.00
0.00
0.0
1.3
—
1.85
—
0
7
0
7
0.00
0.00
0.0
1.0
—
5.54
—
0
7
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
19.18
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
59.20
—
0
5
5
51
0.98
-0.00
2.0
1.5
35.36
28.98
u/l
—
5
44
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_COMBIMMUDEF and mortality.

Females

Parameter HR [95% CI] p-value
D3_COMBIMMUDEF 1.981 [1.72, 2.29] < 0.001
Birth year 0.995 [0.99, 1.0] 0.207

During the follow-up period (1.1.1998 — 31.12.2019), 454 out of 1489 females with D3_COMBIMMUDEF died.

Males

Parameter HR [95% CI] p-value
D3_COMBIMMUDEF 2.256 [1.92, 2.65] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 516 out of 1183 males with D3_COMBIMMUDEF died.

Mortality risk

Mortality risk for people of age

years, who have D3_COMBIMMUDEF.

N-year risk Females Males
1 0.171% 0.394%
5 1.141% 2.075%
10 2.912% 5.699%
15 5.574% 11.202%
20 9.77% 18.871%

Relationships between endpoints

↥

Index endpoint: D3_COMBIMMUDEF – Combined immunodeficiencies

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data